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Abstract 
 
EXPERIMENTAL MACROPHAGE POLARIZATION: A TWO-PRONGED APPROACH 
TO EVALUATE MODULATION OF MACROPHAGE FUNCTION 
 
Charles Fee Hodgman 
B.S., University of Oregon 
M.S., Appalachian State University 
 
Chairperson:  Kevin A. Zwetsloot 
 
Monocytes and macrophages (MMs) are key effector cells of the innate immune 
system, and recent studies have implicated these cells in a wide array of additional 
homeostatic functions. Therefore, uncovering the stimuli that drive changes in MM function 
may yield important findings with far-reaching impact. PURPOSE: The purpose of this 
study was to create a procedure for testing the effects of human exercise and/or dietary 
interventions on macrophage function in vitro, after the incubation of macrophages with 
human subject serum. METHODS: This study involved three parts: 1. Protocol optimization 
for the differentiation of THP-1 monocytes to monocyte-derived macrophages (MDMs) 
using PMA; 2. Optimization of the LPS concentration for polarization of THP-1 MDMs to 
M1 macrophages; 3. Optimization for incubation of THP-1 MDMs with human serum prior 
to M1 polarization. For all optimizations, phagocytic capacity was determined relative to 
untreated controls using a commercially available kit. Additionally, prior to phagocytosis 
measurements, culture media was reserved and the concentration of cytokines IL-10, TNF-a, 
IL-1b, and IL-6 were analyzed for select samples. Finally, NucBlue staining immediately 
following phagocytosis measurements in the latter
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two optimization experiments was used to qualitatively assess effect of treatment on cell 
numbers. Phagocytosis data were analyzed using a one-way ANOVA. Additionally, a two-
way ANOVA was used to determine the effect of time x concentration in serum experiments. 
The level of significance for all analyses was set a priori to the level of 0.05 and, following a 
significant F-statistic, post-hoc analyses were conducted using Bonferroni Correction. 
Cytokine data was not subjected to statistical analysis due to insufficient sample numbers. 
RESULTS: There was a significant effect of PMA incubation time such that 48/24 hr 
incubation/rest led to greater phagocytosis than the longer incubations (𝑝 < 0.01), and a 
trend towards greater phagocytosis than 24/48 hr incubation/rest (𝑝 = 0.065). The 24/48 
condition led to the highest levels, 48/24 condition led to intermediate levels, and 72 hr 
condition led to the lowest levels of all cytokines but IL-1b. There was no significant effect 
of LPS concentration on phagocytosis (p=0.386), though 0.5 µg/mL LPS led to the highest 
phagocytosis. Cytokine responses were similar for all cytokines but IL-1b in which a plateau 
in response was observed with 0.2, 0.5, 1.0 µg/mL LPS. There was a significant effect of 
serum concentration across time (𝑝 < 0.01) and incubation time across concentrations (𝑝 <
0.001), such that higher concentrations and longer incubation times were associated with 
higher and lower phagocytosis, respectively. Similar trends were observed in the cytokine 
data. CONCLUSION: The results of this study inform the following optimized procedure: 1. 
THP-1 monocyte differentiation to MDMs via 48 hr incubation with 25 nM PMA followed 
by 24 hr rest; 2. Incubation of MDMs with 35% human serum media for 3.0 hr before 
polarization. 3. THP-1 MDM polarization with 0.5 µg/mL LPS for 24 hr prior to the 
phagocytosis and cytokine measures.  
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Chapter 1: Introduction and Literature review 
Introduction 
 
Macrophages are phagocytic cells of the innate immune system, most known for their 
role in pathogen clearance, tissue remodeling, and antigen presentation (28). However, 
specific populations of macrophages are also integrally involved in bone, spleen, and central 
nervous system homeostasis (24, 83). In order to fill these diverse roles, the functionality and 
phenotype of macrophages is uniquely plastic in nature (7). Macrophage function can vary 
widely depending on the specific suite of signals present in the tissue microenvironment (23). 
In addition to tissue specific subsets (e.g. osteoclasts in bone), soluble proteins and direct 
interaction with other cells can polarize (i.e. differentiate) macrophages toward either pro-
inflammatory and microbicidal or anti-inflammatory and immunosuppressive phenotypes 
(64). These two divergent phenotypes have been classified as “M1” and “M2” macrophages, 
respectively, in analogous convention to Th1 and Th2 classifications of immune response 
(65). Though conceptually useful, macrophages in vivo likely manifest a continuum between 
these two extremes rather than binary M1 versus M2 (7, 65). Additionally, recent discoveries 
in developmental biology and epidemiology have shed light on the wider importance of these 
cells in tissue development, homeostasis, and disease (24, 28, 83). Consequently, 
understanding of the varied roles and significance of macrophages is expanding (64). 
Harnessing macrophage plasticity holds promise for increasing understanding of health, 
disease, and creating novel treatment options (64, 65). 
 Macrophage polarization both requires and manifests specific changes in cellular 
metabolism (45). Pro-inflammatory M1-type polarization includes upregulation of anaerobic 
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glycolysis, while M2-type macrophages rely more heavily on fatty acids to fuel oxidative 
phosphorylation (7, 64). These changes are an example of “form follows function” wherein 
the glycolytic metabolism showcased by M1-type macrophages supports rapid response and 
clearance of pathogens, while the consistent energy supply of oxidative phosphorylation fuels 
the often prolonged processes of tissue repair, remodeling, and the resolution of 
inflammation (64). However, aberrant appropriation of these phenotypes is associated with 
pathological states (65). For example, adipose tissue in obesity showcases excessive 
recruitment and polarization of adipose tissue macrophages (ATMs) towards the M1 state 
(45). This change in ATM population leads to pronounced inflammatory cytokine production 
fueling chronic systemic inflammation and initiating the path to insulin resistance (45). 
Conversely, virtually all known tumors actively recruit monocytes and macrophages causing 
them to assume pro-tumor, immunosuppressive, and metastatic functions (7). Beyond these 
two examples, macrophages are integrally involved in almost every known disease (83). The 
specific conditions may differ between disease states, but the unifying theme includes 
dysregulation of normal macrophage polarization and plasticity (40, 64, 65). Therefore, 
identifying means to differentially modulate or optimize macrophage polarization may reveal 
new therapeutic options. Of particular interest, diet and activity may have profound effects 
on monocytes and macrophage polarization.  
Given the known associations of healthy diet and exercise with reduced morbidity 
and mortality, it is of interest to what extent these effects are mediated through the immune 
system (6, 59). So far, evidence in both mice and humans indicates that diet and exercise 
improve markers of disease and inflammation through changes in monocyte and macrophage 
polarization. In a mouse model of diet-induced obesity, exercise training was shown to 
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decrease macrophage recruitment into adipose tissue, pro-inflammatory signaling, and the 
inflammatory potential of ATMs (33). These changes were despite no differences in weight 
loss relative to the sedentary group, indicating the potential of exercise to specifically alter 
macrophage function and character (33). In elderly adult humans, 12 weeks of concurrent 
aerobic and resistance training reduced the proportion of CD14+/CD16+ (inflammatory) 
monocytes in circulation, as well as monocyte pro-inflammatory cytokine production (70). 
Again, the latter changes were despite no significant differences in body weight or % body 
fat over the course of the study (70).  
As for diet, monocytes and macrophages are known to be sensitive to different 
macronutrients and accumulating evidence points towards the ability of plant chemicals 
(phytochemicals) to affect the phagocytes’ metabolic functions. Both high glucose and free 
fatty-acids (FFAs) can initiate macrophage polarization towards an inflammatory M1 state 
(64, 65). However, perhaps paradoxically, consumption of carbohydrate during exercise is 
known to reduce both the stress-hormone and inflammatory cytokine response to the bout 
(5). Additionally, monocytes incubated with serum from athletes consuming bananas during 
extensive cycling exercise showed improved mitochondrial function compared to serum from 
athletes consuming a sports-drink or water only (53). Similar results were observed in a study 
by a different group, which found that polyphenolic extract from cocoa beans led to 
improved mitochondrial function as well as decreased inflammatory cytokine secretion in 
THP-1 monocyte-derived macrophages (MDMs)  (22). In sum, research on the 
immunomodulatory effects of diet and exercise points towards the power of lifestyle 
practices to alter, support, and improve macrophage form and function. By more clearly 
delineating these relationships it may be possible to titrate diet and activity interventions to 
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specifically alter macrophage polarization on a case by case basis. Failing that, further insight 
could inform broad recommendations to support macrophage plasticity and prevent the 
inflexibility associated with many diseases (45, 65). It was the goal of this project to develop 
and optimize a two-part procedure for measuring monocyte-derived macrophage function 
and inflammatory character for future use evaluating exercise and dietary interventions. 
In order to accomplish this goal, a multi-step procedure was developed to 
differentiate THP-1 monocytes to macrophages and then polarize the macrophages towards 
an M1-type phenotype. The first set of experiments involved comparing four differentiation 
protocols to optimize this process for later experiments.  Differentiation of THP-1 monocytes 
to MDMs was initiated using the protein kinase C activator phorbol 12-myristate 13-acetate 
(PMA). PMA is the standard method for differentiating THP-1 monocytes and leads to 
MDMs that compare favorably to primary cells (15, 62). The next two stages of experiments 
involved optimization for the concentration of lipopolysaccharide (LPS), and for the 
incubation time and concentration of human serum leading to a robust and consistent 
increase in phagocytic function and cytokine secretion in THP-1 MDMs. Phagocytosis and 
increased inflammatory cytokine secretion are defining characteristics of M1 polarization, as 
well as key to M1 functions (11). Therefore, it was important for this and future projects to 
characterize both phagocytic function and the secreted cytokines following differentiation, 
serum incubation, and polarization. Phagocytic function was assessed using a commercially 
available kit (Vybrant Phagocytosis Assay Kit, ThermoFisher Scientific) and the 
concentration of secreted cytokines was measured using a multiplex, magnetic bead-based 
assay (Milliplex, MilliporeSigma). Finally, cell numbers were qualitatively assessed using 
NucBlue Staining (NucBlue Live ReadyProbes, ThermoFisher Scientific) during the LPS and 
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human serum optimizations to determine whether observed changes were due to alterations 
in cell behavior versus cell numbers. 
 
Literature Review 
Monocytes and Macrophages Overview: What they are, and What they do. Monocytes and 
macrophages are cells of the innate immune system that play integral roles in pathogen 
recognition, clearance, and tissue homeostasis (4). Specifically, monocytes and macrophages 
(MMs) are notable for their ability to phagocytose (engulf) debris and pathogens, leading to 
production of soluble signaling molecules and elimination of the target (64). As a part of the 
innate immune system, MMs arose approximately 500 million years ago shortly after the 
origin of single cell eukaryotes (24, 64). With the evolution of multi-cellular eukaryotes and 
adaptive immunity, MM function expanded to include activation of the adaptive immune 
system in addition to pathogen recognition and clearance (23, 64). MM functions continued 
to diversify as tissue specific populations emerged in more complex organisms (24, 83). 
MMs are highly plastic cells and the specific suite of signals within the tissue 
microenvironment directly and profoundly impacts their form and function (64). In response 
to both soluble mediators and physical interactions, MMs are differentiated and polarized 
towards a variety of functional subsets (7). This plasticity allows unique populations of 
macrophages to express features that support the specific needs of the tissue in which they 
reside. However, it also lends itself to perversion by pathogens or tissue dysfunction (83). 
Due to their widespread distribution, and their pivotal role in health and disease, MMs hold 
great potential for understanding the wider role of the immune system in organismal biology. 
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Furthermore, exploring the mechanisms of MM polarization offers a unique path to treat both 
acute and chronic disease. 
Despite their primordial origins, monocytes were not recognized by science until the 
mid-19th century when they were characterized microscopically by Paul Ehrlich and 
functionally by Elie Metchnikoff (28). It was for this pioneering work on innate immunity 
that the two jointly received the 1908 Nobel Prize in Physiology or Medicine (28). However, 
it was not until 1910 that the term monocyte was first used to describe those cells and until 
1924 that the term macrophage was introduced (23, 28). At this time MMs were classified as 
part of the reticuloendothelial system that also included fibroblasts, endothelial, and reticular 
cells (23). However, in the 1960’s the mononuclear phagocyte system (MPS) was introduced 
to reclassify MMs ontogenetically (23, 28). This classification system, still used today, 
includes monocytes, macrophages, dendritic cells, and their bone marrow precursors (28, 83). 
In conjunction with the creation of the MPS classification, a hierarchical model of 
differentiation was introduced to describe the origins of each cell type (24). In this model, 
monocytes and dendritic cells differentiate from a common “monocyte-macrophage/dendritic 
cell precursor” (MDP), and macrophages mature from monocytes as the latter enters the 
tissue niche (27, 28). This paradigm had dominated until very recently despite early evidence 
of alternative developmental pathways (7, 24, 27, 28). However, recent work tracking the 
ontogeny of tissue resident macrophages has led to a broad revision of MM development and 
even suggestion that different tissue macrophages should be classified as distinctive cell 
types (64, 83). Conversely, rather than “immature” macrophages, monocytes may represent a 
dynamic “emergency squad” capable of patrolling and responding to disruptions in tissue 
homeostasis (28). 
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Monocytes. Due to the difficulty of isolating and maintain primary MM cells from human 
subjects, the majority of what is known about MM biology is derived from mouse studies 
(24, 83). Therefore, the majority of the following data applies specifically to mice, unless 
otherwise noted. However, despite some particular differences, it appears that murine and 
human MMs function vary similarly (83). So, conclusions drawn from animal studies are still 
broadly informative. Within the divisions of the MPS system multiple populations of both 
monocytes and macrophages have been observed. In bone marrow of adults, immature 
monocytes differentiate from MDPs (24, 27). These monocyte forerunners are positive for 
the cell surface marker Ly6c and have no phagocytic capacity (24). Following stimulation by 
CCL2/MCP-1, Ly6c+ monocytes proliferate and egress from the bone marrow into the 
circulation where they constitute ~4% of circulating leukocytes in mice and ~10% in humans 
(28). Circulating monocytes are composed of two subsets, differentiated by their expression 
of the cell surface marker Ly6c (24, 28). Ly6c+ cells, known as “classical monocytes,” are 
the first to emerge from the bone marrow, and possess greater inflammatory potential (28, 
65). Classical monocytes circulate for approximately 70 hours before either entering tissues 
and differentiating into macrophages, or differentiating into Ly6c- monocytes (23). Ly6- 
monocytes, known as “non-classical” or patrolling monocytes, have lower inflammatory 
potential but may persist in the circulation for up to 7 days (28). While both monocyte 
subsets patrol the circulation searching for problems, they perform divergent functions. 
Ly6c+ monocytes form an “emergency squad” most responsive to CCL2/MCP-1, but 
sensitive to a variety of chemokines which cause the cells to migrate into inflamed tissue and 
differentiate into MDMs (24, 28, 64). Conversely, Ly6c- monocytes express higher levels of 
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adhesion molecules and, though capable of extravasation, primarily function to monitor and 
maintain the vascular endothelium (24).  
Though pioneering work on monocytes was conducted in mice, analogous 
differentiation patterns and populations have been characterized in humans. Human classical 
and non-classical monocytes are identifiable as CCR2+/CD14+/CD16- and CX3CR1+/CD14-
/CD16+, respectively (28, 65). Humans also possess a third intermediate monocyte 
population that is CD14+/CD16+ and may represent a transitional phenotype with its own 
functionality (27). Similar to the Ly6c+ to Ly6c- transition observed in mice, repopulation 
studies have shown that human monocytes progress from CD14+/CD16- to CD14-/CD16+ 
with parallel changes in function (28). However, differences do exist between murine and 
human monocyte biology, particularly in the distribution of the subsets. While mouse 
monocytes are fairly evenly distributed between Ly6c+ and Ly6-, human classical monocytes 
compose 80-90% of the circulating population with intermediate and non-classical 
monocytes forming the remaining 10-20% (28). In addition, mouse monocytes do not and 
human monocytes do express major histocompatibility complex II (MHC-II) proteins, 
indicating functional differences in regard to antigen presentation (28). 
Macrophages. For approximately 50 years since the introduction of the MPS system 
macrophages have been viewed as “mature” monocytes, the end result of monocyte 
differentiation following extravasation into the tissue (24). However, this was despite 
evidence to the contrary both in the 1960’s and even as far back as Elie Metchnikov (24, 83). 
In the last 15 years, studies on macrophage population and repopulation have expanded 
conceptions on macrophage origin (83). The latter findings have not re-written the monocyte 
to macrophage pattern so much as diversified the definition of what macrophages are and 
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where they come from. Most notably, it is now accepted that the majority of tissue resident 
macrophages have embryonic origins and, rather than consistent repopulation by monocytes, 
self-renew in situ (24). The following section will cover an overview of these recent findings 
on macrophages during development, and then discuss the phenotypic and functional 
characteristics that discriminate different macrophage populations. 
In mice, the first macrophages to develop derive from the embryonic yolk sac 
ectoderm around embryonic day 8 (83). At this point, these primitive macrophages are the 
only leukocytes present and this particular population goes on to colonize and perform 
trophic functions in the majority of the major organs (24, 32, 83). By embryonic day 10 
hematopoietic stem cells (HSCs) become the main source of macrophages, proliferating and 
differentiating in the liver until shortly after birth when bone marrow becomes the main site 
of HSC differentiation (24). Liver-derived macrophages supplement the populations in all the 
previously mentioned tissue niches except the brain, whose population of macrophages is 
exclusively yolk sac-derived (24, 83). Following birth, the majority of tissue resident 
macrophages self-maintain with little supplementation by monocytes except in the case of 
injury or inflammation (24). The notable exceptions to this rule are macrophages in the 
digestive tract and osteoclasts in bone (27, 64). The digestive tract features a mixture and 
self-renewing resident macrophages supplemented by MDMs, while osteoclasts may be 
derived from HSCs or circulating monocytes (27, 64). Resident macrophages in each tissue 
niche vary widely in their phenotypes and functions, depending on the environment and the 
requirements of the organ (24). These differences have led to the development of 
nomenclature to differentiate resident macrophages from different tissues including: 
Microglia in the central nervous system (CNS), Kupffer Cells in the liver, Langerhans Cells 
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in the skin, Red-Pulp Macrophages of the Spleen, Osteoclasts in bone, and Histiocytes in 
both spleen and interstitial spaces (27, 64). This is not meant to be an exhaustive list of all 
tissue macrophages, rather, it is meant to give an appreciation for tissue macrophage 
diversity and recognition of their functional and phenotypic differences. 
 Regardless of their developmental origin, all macrophages in mice and humans 
express the cell surface receptor CSF1r (83). The ligand for this receptor, colony stimulating 
factor or macrophage colony stimulating factor (CSF/M-CSF), is involved in growth and 
proliferation of most macrophage populations though its specific effects vary between tissue 
niches (83). Additional markers of adult macrophages in mice include: CD11b, CD68, and 
F4/80 (83). CD68 and CD11b are also present in human macrophages, but the human 
equivalent of F4/80 is less diagnostic (27, 32). Additionally, macrophages may be 
distinguished by increased expression of the co-stimulatory proteins CD80 and CD86, though 
this too may vary by macrophage subset (36, 58). In comparison to monocytes, macrophages 
can be reliably identified by increased size and intracellular complexity (3, 23). The latter 
differences reflect changes in phagocytic capacity and are the result of a greater 
concentration of lysosomes and mitochondria (15). Beyond these few general characteristics, 
broad macrophage markers are difficult to confirm because of the diversity and plasticity in 
macrophage subsets. Macrophages in different tissues or functional states may be as 
transcriptionally different from one another as they are from monocytes (24). 
 As mentioned above, MDMs serve to supplement rather to replace tissue macrophages 
following fetal development (24). After entry into the tissue niche, MDMs are tuned towards 
different functional states based on contextual and tissue-specific conditions (64). This process 
is known as macrophage polarization and is described by the M1/M2 macrophage scheme (64). 
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M1 polarized macrophages, also known as classically activated macrophages, are the 
prototypical inflammatory macrophages tuned to fight viral and bacterial infection with 
cytotoxic functions (65). In contrast, M2 polarized macrophages, also known as alternatively 
activated macrophages, have a variety of functions including: anti-parasitic, anti-
inflammatory/immunosuppressive, and tissue remodeling (23, 65). The wide variety of 
functions encompassed by M2 macrophages is indicative of the limitations of the M1/M2 
scheme and dramatic plasticity of macrophages. At least four subsets have been identified 
within the M2 classification (M2a, b, c, d), all with variable expression patterns and divisions 
between them (23, 36). Furthermore, additional classes of macrophages have been identified 
that defy either M1 or M2 categorization (7, 9). Although the paradigm does have its limit, 
characterizing macrophages as M1 or M2-like is operationally useful and significant research 
has defined the changes associated with polarization towards either state.  
M1 polarization is induced by bacterial lipopolysaccharide (LPS) alone or in 
combination with the cytokines IFNg, TNFa, and/or GM-CSF (23, 64, 65). M1 macrophages 
mediate their inflammatory and anti-microbial functions through the release of reactive oxygen 
and nitrogen species (ROS/RNS), as well as the prolific production of inflammatory cytokines 
such as TNFa, IL-1b, IL-6, and IL-12 (65). M1 macrophages also possess potent phagocytic 
capacity, recruit additional immune cells to the site of infection, and promote a Th1-type 
adaptive immune response via the chemokines CXCL9 and CXCL10, as well as increased 
expression of CD80/86 and MHCII (23, 36, 65). In order to execute a rapid and potent 
inflammatory response, M1 macrophages undergo significant transcriptional changes during 
polarization, including metabolism (7, 9, 64). Besides increased expression of genes coding 
for inflammatory cytokines and chemokines, M1 polarization is associated with a dramatic 
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shift towards the anaerobic metabolism of glucose (64). This shift in energy metabolism 
supports M1 inflammatory function through the rapid production of ATP (64). Additionally, it 
allows citrate to be diverted from the Kreb’s Cycle towards synthesis of ROS, RNS, and 
prostaglandins (64). Taken together, the features of M1 polarization support robust, rapid 
induction of inflammation, and recruitment of additional cytotoxic cells to contain and 
eliminate potential threats.  
In contrast to M1-polarized macrophages, M2-polarized macrophages are tuned for 
resolution and repair following inflammatory events. Prototypical M2 polarization is induced 
by the cytokines IL-4, IL-13, IL-10, and TGF-b, and/or the phagocytosis of necrotic tissue (4, 
36, 40). M2 macrophages promote a Th2-type immune response and the resolution of 
inflammation through the production of the cytokines IL-10, TGF-b, VEGF, and IGF-1 (23, 
65). To support their role in tissue remodeling, M2 polarized macrophages have high 
phagocytic capacity, but are poor antigen presenting cells (APCs) due to lower expression of 
MHCII and CD80/86 (36, 65). Additionally, these cells express a variety of degradative 
enzymes, such as metalloproteinases, for breaking down extracellular matrix (23). In response 
to parasitic infections M2 macrophages recruit the help of eosinophils and basophils with the 
chemokines CCL17, CCL22, and CCL24 (65). Compared to M1 macrophages, M2 
polarization involves relatively little transcriptional changes (9, 42). The majority of changes 
that occur during M2 polarization appear to involve genes associated with lipid metabolism, 
tissue growth and degradation, and extracellular pathogen response (42). 
The features listed above are generally associated with M2 macrophages, but the degree 
to which they apply to the four defined M2 phenotypes varies between the subsets. Of the four, 
the M2a phenotype identifies most closely with the classic definition of alternatively-activated 
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macrophages and these macrophages are tuned to facilitate the clearance of cellular debris, as 
well as resolve inflammation and injury (64).  Conversely, M2b macrophages appear to 
participate more actively in inflammatory immune responses as they are induced by some of 
the same stimuli as M1 macrophages (64). M2c polarized macrophages primed to specifically 
aid in clearance of  cellular debris through the expression of scavenger receptors and anti-
inflammatory cytokines (36, 64). Finally, M2d macrophages are the most competent at 
promoting vascular growth (64). For a more detailed list of M2 macrophage features please 
refer to Table 1 below. Despite the overarching designation as “M2 macrophages,” the wide 
variety of stimuli and expression patterns listed above indicate that M2 macrophages may 
actually be more different than they are similar. The features that link these different 
populations may be less associated with similarity in expression patterns or functionality, and 
more related to the facility with which they transition from one phenotype to another. This 
phenomenon, known as macrophage re-programming or re-polarization, turns out to be a 
defining trait of macrophages that contributes to their diversity (2, 7, 64). 
Class Induced By Express Secrete 
M2a IL-4, IL-13 CD206, IL-1Ra, IL-
1R, Arg-1 (Mice), 
FIZZ1 (Mice), 
Ym1/2 (Mice) 
IL-10, TGF-b, 
CCL17, CCL18, 
CCL22, CCL24 
M2b Antigen-Antibody 
Complexes, 
Apoptotic Cells, 
LPS, IL-1Ra, IL-1b 
CD86, MHCII IL-1, IL-6, TNF-a, 
IL-10 (high) 
M2c IL-10, TGF-b, IL-
1Ra, glucocorticoids 
CD163, CD206, 
TLR-1, TLR-8, Arg-
1 (mice) 
IL-10, TGF-b, 
CXCL13, CCL16, 
CCL18 
M2d LIF, Il-6, Adenosine IL-10 (high), VEGF 
(high), IL-12 (low), 
TNF-a (low) 
IL-10 (high), VEGF 
(high), IL-12 (low), 
TNF-a (low) 
Table 1: Features of M2 macrophage subsets. Compiled from (23, 36, 64). 
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Given the wide variety of characterized functional states, and the theoretically infinite 
mixtures of polarizing stimuli, macrophages in vivo likely reflect a continuum between the 
established M1 versus M2 (or M2a) extremes rather than discrete subsets (65, 83). The 
concept of macrophage polarization is further complicated by the lability of macrophage 
polarization states, and potential limitations set by tissue microenvironments. Following the 
absence of polarizing stimuli or prompting from opposite stimuli, polarized macrophages 
may revert to the original “M0” state or transition from one functional state to another (i.e. 
M1 « M2) (7, 23). This remarkable plasticity appears essential to the progression of a 
healthy inflammatory response, and disruption of facile transitioning between polarization 
states is associated with a variety of diseases and poor healing (28, 64, 65). Nevertheless, the 
degree of plasticity does vary and may be purposefully governed between different tissue 
niches. For instance, regardless of their origin (i.e. resident or MDM) macrophages in the 
lung exhibit a more anti-inflammatory M2-like phenotype (65). This feature may limit 
inflammation-induced damage to the delicate tissue of the alveoli (64). In contrast, 
macrophages in the digestive tract exhibit a unique phenotype characterized by high M1-like 
bactericidal activity, but low inflammatory cytokine production (27). The latter traits appear 
to prevent dysbiosis by eliminating harmful bacteria, while concurrently fostering tolerance 
to beneficial bacterial populations (64). Thus, plasticity and diversity are essential features of 
macrophages leveraged for both immunologic functions and tissue homeostasis (7). In 
summary, more than simply effector cells of the innate immune system, macrophages are an 
endlessly diverse and dynamic population of cells employed as guardians of local and 
systemic homeostasis. 
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Monocytes and Macrophages: Why they matter. The facility with which macrophages re-
polarize or re-program is more than a coincidence of their diversity. Rather, switching 
between phenotypes is integral to macrophage functions in promoting and resolving 
inflammation (4, 24, 28). However, the sensitivity of macrophages to their environment and 
their remarkable plasticity also leaves them susceptible to dysfunction in chronic disease, or 
exploitation by pathogens (64, 65). The following section will summarize a number of 
examples which showcase the utility of macrophage re-programming as well as how this 
process is disrupted during pathological states. 
Analogous to an infectious insult, facilitating an effective and efficient healing 
response to physical trauma is central to macrophage function. Importantly, both M1 and M2 
polarized macrophages serve distinctive roles in healing, and active transition between the 
two states appears essential for an optimal healing response (4, 28). In a seminal study by 
Arnold et al., MDM recruitment, phenotype, and tissue healing were observed following 
experimentally-induced skeletal muscle injury in mice (4). The investigators were most 
interested in examining whether the different MDM populations present at different stages of 
healing were representative of discrete invasions by different monocyte subsets, or one 
population with a transitioning phenotype (4). Over the course of multiple experiments, the 
authors concluded that the initial inflammatory response is induced following Ly6c+ 
monocyte invasion, M1 polarization, and pro-inflammatory cytokine production (4). 
However, the decline in inflammatory MMs starting approximately 24 hours after injury 
occurred via re-programming of the initial invaders rather than new MDMs. Notably, 
phagocytosis of necrotic tissue and IL-4 production by muscle progenitor cells (MPCs) were 
shown to be essential to the transition of MMs from an inflammatory (i.e. Ly6c+/M1) to an 
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anti-inflammatory (Ly6c-/M2) phenotype (4). Both the inflammatory and anti-
inflammatory/resolution stages of healing were essential to an effective healing response, 
with Ly6c+/M1 MMs important to MPC growth and proliferation and Ly6c-/M2 MMs 
responsible for MPC differentiation and fusion (4). The results of this study show the 
importance of both inflammatory and anti-inflammatory MMs, as well as effective 
macrophage reprogramming. They also suggest that overuse of anti-inflammatory 
interventions (i.e. NSAIDs, icing) in response to pain and injury may actually delay or impair 
the healing process. 
 Another example demonstrating the importance of macrophage polarization and 
plasticity is the systemic response to infection. During infection, the production of 
inflammatory cytokines (particularly TNF-a) induces a state of peripheral insulin resistance 
(65, 83). This response may save glucose for inflammatory cells, like M1 macrophages, that 
are primed for rapid glucose uptake and ATP production through anaerobic glycolysis (64, 
83). Additionally, high glucose environments are capable of polarizing MMs towards the M1 
state (64). This indicates glucose may serve as an immune signaling molecule to bolster the 
inflammatory response. However, while useful during brief infections, inflammation-induced 
insulin resistance and pro-inflammatory macrophage character become etiological in a 
number of diseases when prolonged (83). Chronic, sterile inflammation is symptomatic of 
obesity and linked to the progression of cardiovascular disease, non-alcoholic fatty liver 
disease, insulin resistance, and type-2 diabetes (7, 45). Understanding the role of 
inflammation and glucose on insulin resistance and macrophage polarization, it is logical to 
conclude that the ability of MMs to re-program towards an anti-inflammatory phenotype and 
reduce inflammation is essential to disease prevention. This hypothesis is supported by 
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studies show reductions in inflammatory cytokine production and re-programming MM 
following both exercise interventions and weight loss (25, 33, 70). Thus, similar to wound 
healing, rapid macrophage polarization and re-programming is essential for mounting and 
resolving an efficient response to infection. 
 Finally, perhaps the best example of the essentiality of macrophage polarization and 
plasticity is in the context of cancer. As a part of their inflammatory and cytotoxic phenotype 
M1 polarized macrophages are mostly tumoricidal (23). However, chronic activation and 
inflammation induced by M1 macrophages may lead to DNA damage that is causal in 
tumorigenesis (64, 65, 83). In contrast, most established tumors appear to “re-educate” 
macrophages toward an immunosuppressive, pro-angiogenic phenotype that most closely 
resembles M2d polarization or, perhaps, a developmental macrophage phenotype (7, 83). At 
the site of tumorigenesis, tumor associated macrophages (TAMs) are mostly derived from 
resident macrophages (28). These cells enable tumor growth by modifying existing 
extracellular matrix and specifically localization to hypoxic areas to promote angiogenesis 
(37). Additionally, TAMs are poor APCs and prevent tumor cytotoxicity through the 
production of anti-inflammatory cytokines and low production of IL-12 (64). Concurrently, 
metastasis is facilitated by monocytes recruited to colonize future tumor sites, perhaps by 
tumor released exosomes (28, 83). The importance of TAMs to cancer progression is evident 
from studies correlating the density of TAMs with poor prognosis and showing TAM 
depletion inhibits tumor vascularization and growth (7, 64). Therefore, identifying the signals 
that induce the TAM phenotype and targeting TAM polarization and plasticity is an attractive 
avenue for anti-cancer therapy. It is possible that TAM re-programming or supporting 
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macrophage plasticity could prove a powerful supplement in cancer treatment, if not cause 
spontaneous remission on its own. 
 The previous three examples showcase the importance of macrophage polarization 
and the dysfunction that can occur with the misappropriation of polarization states or 
disruptions to macrophage plasticity. Although inflammation is frequently designated “bad” 
and anti-inflammatory agents “good,” hopefully the evidence detailed above illustrates that 
both inflammatory and anti-inflammatory potential are indispensable to effective 
macrophage function and systemic homeostasis. In thinking about future research avenues 
and potential therapeutic options, less emphasis should be placed on reinforcing a specific 
macrophage polarization state than on supporting appropriate sensitivity to stimuli and the 
ability to re-program following stimulation (65). The “right” polarization state is extremely 
context specific, therefore the benefit of inducing one functional state or another without 
adequate plasticity may lead to unforeseen complications. Fortunately, strategies to balance 
and maintain macrophage polarization and plasticity may already exist. In this vein, research 
into the beneficial effects of lifestyle interventions have shown promise in modulating 
macrophage phenotype. 
Monocytes and Macrophages: Optimizing Response. With the understanding of MMs 
integral nature in the development and homeostasis of almost every tissue environment, it is 
clear that identifying means to modulate macrophage polarization and maintain plasticity 
offer distinct potential for improving and maintaining physiological function. Additionally, 
given the long lifespan of tissue macrophages, optimal versus impaired macrophage function 
may dictate long-term health (65). The question is, what are the best tactics to support MM 
function? Along these lines, a number of different strategies have started to be evaluated 
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including both targeted and more holistic approaches. Regarding the former, anti-CD14 
antibodies have been evaluated for their ability to blunt excess macrophage inflammatory 
signaling in the etiology of sepsis (20). CD14 is a key cell surface receptor protein involved 
in the LPS signaling, and the development of sepsis and , given its role, anti-CD14 antibodies 
were hypothesized as a potential sepsis counter-measure. However CD14 also appears to 
participate in LPS clearance within the liver so, although anti-CD14 antibodies or 
oligonucleotides reduced inflammatory signaling in vitro, they did not lead to uniformly 
improved survival to sepsis challenge in vivo (20). Consequently, until understanding 
regarding the complexities of macrophage polarization and signaling are more refined, more 
judicious approaches may be warranted. Fortunately, the search for alternatives need not be 
exhaustive since interventions as mundane as exercise and diet may be remarkably potent. 
 It is well established that a healthy diet and remaining active are essential supporting 
physical and mental vitality. However, the means by which exercise and diet specifically 
support well-being have yet to be fully defined. Both exercise and the consumption of certain 
foods are known to have beneficial anti-inflammatory effects (25, 30, 69). Yet, how these 
effects are mediated and the correct dose to affect an optimal response remain to be 
elucidated. Given their atypical responsiveness, plasticity, and widespread distribution MMs 
are prime candidates. Furthermore, there is evidence to support MMs are one target for the 
effects of diet and exercise. 
 In the context of increasing inflammation associated with age or chronic disease, 
exercise is a known to decrease or blunt such “inflammaging” and sterile inflammation (5, 
25, 45). Despite this association, the mechanisms mediating the anti-inflammatory effects of 
exercise are just beginning to be discovered. So far, the evidence supports three main 
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strategies through which exercise modulates systemic inflammation: decreasing adiposity, 
anti-inflammatory signaling, and changing MM character.  
In healthy adipose tissue, adipose tissue macrophages (ATMs) perform stromal 
functions, exhibit characteristics of M2 polarization, and maintain insulin sensitivity through 
the production of IL-10 (45, 83). However, adipose tissue stress induced by excess energy 
consumption or circulating free fatty acids (FFAs) leads to a cascade of maladaptive events 
including: increased pro-inflammatory signaling (e.g. MCP-1, LTB4, TNF-a), monocyte 
recruitment, MDM M1 polarization, and adipocyte apoptosis (45, 83). Consequently, adipose 
tissue in obesity or overnutrition becomes a site of prolific pro-inflammatory cytokine 
production concurrently inducing the release of additional FFAs and contributing to local and 
systemic insulin resistance (65). The central role of ATMs in adipose tissue inflammation 
and dysfunction is evident from experiments in which ATM depletion led to improved 
insulin sensitivity and glucose tolerance (45). Additionally, weight loss through the reduction 
of adipose tissue mass is associated with lower markers of systemic inflammation and a 
restoration of a healthy ATM population (25, 65). Given diet and exercise are the most 
common and effective weight-loss strategies, it is clear they can indirectly modify systemic 
inflammation through reductions in adipose tissue mass. 
At a more acute level, there is also evidence to indicate that exercise can directly 
affect inflammatory vs. anti-inflammatory signaling. It has been observed that exercise 
induces a transient anti-inflammatory state following each bout (25, 74). This phenomenon 
may be  contradictorily explained by inflammatory signaling during exercise, specifically the 
release of IL-6 (66, 68, 81). IL-6 infusion at levels similar to those observed during exercise 
has been shown to induce release of the anti-inflammatory cytokines IL-1ra, IL-10, and the 
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hormone cortisol (68). Additionally, IL-6 may blunt TNF-a and IL-1b signaling and promote 
a higher M2:M1 macrophage polarization balance (66, 74). Consequently, frequent doses of 
exercise-induced IL-6 signaling with habitual activity may summate to attenuate chronic 
low-grade inflammation (25). Evidence also exists to suggest consistent exercise may have 
immunological effects outside the context of each exercise bout. 
As detailed above, weight loss is associated with a reduction in systemic 
inflammation and improvements in adipose tissue health whether with or without exercise 
(26, 64, 65). However, there is evidence to indicate that exercise may alter MM phenotype 
and decrease pro-inflammatory signaling even in the absence of weight loss. In a study by 
Kawanishi et al., introduction of a treadmill running program led to a reduction in adipose 
tissue MDM recruitment, MDM TNF-a production, and re-programming of ATMs towards a 
M2 phenotype in a mouse model of diet-induced obesity (DIO) (33). Notably, this was 
despite no differences in food intake or weight loss compared to the sedentary DIO group 
and, overall, exercise training caused a normalization of inflammatory cytokines and ATM 
character towards mice undergoing exercise training on a standard diet (33). Remarkably, 
similar results have also been shown in humans. As reported by Timmerman et al., twelve 
weeks of concurrent aerobic and resistance exercise training led to a reduction in circulating 
inflammatory monocytes, lower monocyte TLR4 expression, and a reduction in ex vivo basal 
and LPS stimulated TNF-a production (70). The latter changes were despite no significant 
changes in body mass, BMI, or percent body fat over the course of the study, indicating 
specific effects on monocytes themselves (70). Interestingly, when compared to those of 
physically active adults of the same age, the characteristics of the previously sedentary group 
undergoing training trended towards those of the physically active cohort (70). This suggests 
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that commencing physical training later in life may still offer similar benefits to life-long 
training in sedentary, but otherwise healthy elderly adults. 
In the context of macrophage polarization and plasticity, the obvious caveat to the 
anti-inflammatory effects of exercise listed above is whether encouraging an anti-
inflammatory environment is always warranted or wanted. MMs and other cells produce 
cytokines for the purpose of inflammatory signaling (23). Despite its negative connotations, 
both cytokine-dependent and independent inflammation has many essential functions 
including the mobilization of monocytes during homeostatic disturbances, containment and 
elimination of pathogens, as well as the previously detailed role in the initial stages of 
healing (4, 23, 28). Therefore, the anti-inflammatory effect of exercise may actually be 
detrimental in certain circumstances, and there is evidence showing this to be the case. It is 
well documented that heavy physical exertion can both acutely and chronically compromise 
immune function (54, 66, 84). For macrophages in particular, abundant evidence has shown 
that both acute exhaustive exercise and chronic heavy exertion can impair the cells’ cytotoxic 
and antigen-presentation functions. Acute exhaustive, but not moderate, exercise is 
associated with reduced macrophage antigen presentation, inflammatory cytokine production, 
and intrinsic anti-viral defense (8, 16, 34, 80). Similarly, chronic heavy physical exertion is 
associated with increased risk for upper respiratory tract infections (URTI) likely mediated 
by impaired macrophage function, among other immune impairments (49, 52, 66, 84). 
However, in contrast to the effects of exhaustive exercise and chronic heavy exertion, regular 
moderate exercise is actually associated with improved immunity and reduced infection risk 
(5, 25). Notably, moderate exercise is associated with reduced risk for URTI (49). There is 
evidence to indicate this reduction is due to improved lung macrophage anti-viral resistance, 
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perhaps mediated by exercise induced increases in the inflammatory cytokine IL-6 (16, 48, 
49).  Additionally, both acute exercise and exercise training are associated with increases in 
macrophage phagocytosis, anti-tumor activity, ROS production, and improved sensitivity to 
the activating signals of LPS and IFN-g (55, 73, 80). Therefore, exercise does not inherently 
suppress nor enhance immune function. Instead, the effect of exercise on immunity appears 
to be dose dependent with habitual moderate physical activity associate with improved 
immunity, yet reduced systemic inflammation (25, 49, 75). But, in heavy doses or in 
conjunction with additional stressors, exercise may lead to compromised immune function 
(25, 46). This biphasic relationship deserves further study as the stress responses of exercise 
mimic many of the same responses to psychological stress (18, 47). Investigations in this area 
may yield novel insight for treating both physiological and psychological ailments. In 
parallel, efforts devoted to bolstering or supporting the beneficial effects of exercise are also 
needed. Fortunately, work in the area of immunonutrition has shown promise both for 
supporting immune function in the face of exercise stress, and also for beneficially 
modulating macrophage polarization. 
Like exercise, a healthy diet and the consumption of certain foods are known to 
support immune function and display anti-inflammatory effects, respectively (5, 19, 73). 
However, unlike exercise, the majority of work examining the anti-inflammatory properties 
of food products has been limited to in vitro work or in animal models (5). From this line of 
inquiry, plant-derived phytochemicals have demonstrated powerful anti-oxidant and anti-
inflammatory properties (12, 37, 85–87). However, the degree to which these results translate 
in vivo or in humans is limited in two regards: the complexity of in vivo signaling dynamics 
and the bioavailability of phytochemicals (21, 39, 61). In regard to the latter point, the 
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activity of phytochemicals in vivo may differ considerably from the native due to extensive 
microbial and hepatic modification following ingestion, and prior to entering the systemic 
circulation (5). However, evidence does exist showing immunomodulatory effects of 
phytochemicals in vivo and demonstrating the transability of in vitro work, at least to a 
certain degree. Despite the potential for high glucose levels to polarize MMs towards the M1 
(pro-inflammatory) state, consumption of carbohydrate during exercise is associated with a 
reduction in the stress hormones and inflammatory response to the bout (54, 64). 
Interestingly, in a recent study comparing the effect of banana versus sports drink or water-
only consumption during an exhaustive cycling bout, banana consumption was associated 
with an increase in circulating banana-related metabolites, improved mitochondrial function 
and reduced COX-2 mRNA expression of THP-1 monocytes incubated with serum from 
banana provisioned cyclists (53). The latter changes were significantly different from the 
water-only condition and there was a trend toward lower COX-2 mRNA expression 
compared to sports-drink consumption (53). Similarly, incubation of THP-1 MDMs with a 
cocoa bean polyphenol extract reduced inflammatory cytokine secretion of M1-polarized 
macrophages and increased ATP production through oxidative phosphorylation (22). There is 
also evidence to indicate that specific nutritional practices may enhance immunity in the face 
of exercise stress, with the potential to directly bolster macrophage function.  
Broadly, carbohydrate ingestion during exercise is a consensus counter-measure to 
exercise-induced immunosuppression by reducing the stress hormone and cytokine response 
to the bout, as well as attenuating some but not all adverse changes in immune cell function 
(5). On a more specific level, various plant-derived components have shown promise in 
boosting anti-viral defenses. Seventeen days consumption of a polyphenol-enriched protein 
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powder was associated with reduced in vitro cytotoxicity to the vesicular stomatitis virus 
when cells were incubated with post-exercise serum from supplemented vs. placebo-
supplemented athletes (1). Additional evidence for the potential of phytochemicals to boost 
anti-viral responses comes from two studies which observed increased natural killer cell 
counts with six weeks consumption of either whole blueberries or a freeze-dried blueberry 
powder in athletes and non-athletes, respectively (43, 44). These studies also observed 
reductions in exercise-induced oxidative stress and increased anti-inflammatory cytokine 
levels in the athletes, and reduced blood pressure in the non-athletes (43, 44). Finally, added 
carbohydrate and/or oat b-glucan consumption has been shown to improve survival rates in 
mice infected with herpes simplex virus following exercise stress, as compared to non-
supplemented mice (17, 50). The latter changes are likely mediated through enhanced lung 
macrophage function (47). Taken together, the results of the experiments listed above show 
the potential for transability of in vitro to in vivo models, as well as the potential for 
nutritional interventions to support immune function and modulate macrophage polarization 
both within and outside the context of exercise. However, more work remains to be done to 
reveal how the observed changes are occurring and uncover additional means to support 
macrophage and global immune function in different contexts. 
In summary, MM polarization and plasticity are essential features to maintaining 
immune health, systemic homeostasis, and are an attractive target for supporting wellbeing in 
the face of infection or aging. To this end, both exercise and dietary interventions have 
shown promise in  supporting immunity and modulating macrophage function. Although, 
identifying the most effective doses and compounds still remains to be determined. 
Therefore, strategies to consistently evaluate the effects of activity and/or nutritional 
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interventions are sorely needed. Ideally these strategies would allow for examination of 
conditions in vivo, without unduly invasive or tedious procedures. It was the goal of this 
project to optimize a procedure for evaluating macrophage function and polarization state in 
vitro following incubation with human subject serum to model in vivo conditions. In order to 
accomplish this goal, a multi-step process was devised to differentiate THP-1 monocytes to 
MDMs and then assess MDM phagocytic function and cytokine secretion in response to 
serum and/or polarizing compounds. 
Monocytes and Macrophages: Modeling In Vivo conditions with Human Cell Lines. For 
optimal translation and applications, ideally, in vivo human studies would be used for 
exploring macrophage polarization. However, due to technical and ethical limitations, 
studying tissue macrophages in vivo or ex vivo is not feasible (80). To circumvent these 
problems both animal models and human monocytes isolated from peripheral blood 
mononuclear cells (PBMCs) have been used; although each alternative presents its own 
limitations either in applicability of results or availability and maintenance of the cells, 
respectively (11, 79). Consequently, human cell lines have been developed for use in 
experiments on MM biology with useful features not found in primary cells including: 
uniform genetic background, the ability for culture expansion, as well as long term culture 
and storage (3, 11). The most commonly used line for the study of human MM biology is the 
THP-1 monocyte line (3). This line of human monocytes was isolated from the circulation of 
a 1-year old male with acute monocytic leukemia in 1980 (71). Subsequent experiments 
revealed the cells behaved similarly to primary monocytes: showing lysozyme production, 
phagocytic activity to sheep red blood cells, and the ability to activate T-cells (71). 
Furthermore, supporting the practicality of the cell line, the cells could be cultured for 
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extended periods of time (months) without adverse genetic changes or diminished 
proliferative capacity (71). Since its establishment, the THP-1 cell line has been used 
extensively in experiments exploring the factors that influence monocytic and MDM 
behavior and function (11, 38). In the latter case, a variety of substances and protocols have 
been evaluated for their ability to differentiate THP-1 monocytes to MDMs, including 
Vitamin D3 and phorbol 12-myristate 13-acetate (PMA) (9, 15, 57, 62). Of the two, PMA 
most reliably differentiates THP-1 monocytes to a phenotype that closely matches primary 
MDMs and, therefore, is the most common compound used in differentiation (9, 15, 38, 62). 
In THP-1 monocytes, PMA appears to mimic diacylglycerol signaling through protein kinase 
C (PKC), a family of enzymes involved in cell proliferation and differentiation (62). PMA 
treatment leads to arrest of proliferation, an increase in size and granularity of THP-1 cells, 
adhesion, and increases in surface markers of macrophage differentiation (15, 62). Despite 
(or perhaps because of) its popularity, numerous PMA differentiation protocols exist leading 
to variable phenotypes (3, 38, 57, 67).  As a consequence of this non-agreement, one study 
aimed to critically compare the most popular differentiation protocols with the aim of 
introducing a standardized protocol for in vitro THP-1 differentiation (38). Following their 
experiments, the authors of the study recommended a differentiation protocol involving 
culture of THP-1’s with 25 nM PMA for 48 hours, followed by 24 hours without PMA prior 
to subsequent experimental interventions (38). This protocol was shown to lead to adequate 
differentiation of the monocytes without excess activation of pro-inflammatory signaling, 
which has been shown to occur with overexposure to PMA (38, 57, 67). 
 Following differentiation, THP-1 MDMs can be polarized towards either the M1 or 
M2 polarizations states using similar substances to those in primary cells (IFN-g + LPS and 
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IL-4, respectively) (9, 11). However, PMA differentiated THP-1 cells MDMs may be more 
amenable to M1 polarization as PMA differentiation does appear to bias the cells towards a 
more inflammatory phenotype (9, 15). Though standard M1 polarization involves incubation 
of differentiated THP-1 MDMs with a combination of IFN-g and LPS, there is evidence to 
indicate that LPS alone may yield a similar polarization state (9). LPS, a pathogen associated 
molecular pattern (PAMP), is an integral component of the cell wall of gram-negative 
bacteria and consequently serves as a soluble indicator of bacterial infection in vivo (20). 
Antigen presenting cells, like monocytes and macrophages, express a wide array of pathogen 
recognition receptors for sensing PAMPs (76). In monocytes and macrophages, LPS signals 
primarily through the PRR TLR4 to activate NF-kB and upregulate inflammatory gene 
expression (20, 56). LPS-TLR4 interactions alone can induce NF-kB activation, however, 
optimal activation involves additional proteins participating in the LPS-TLR4 signaling 
complex (15, 38, 58). In vivo, LPS aggregates are bound by the LPS binding protein (LBP) 
which delivers them to soluble or membrane bound CD14 receptors (56). CD14 splits LPS 
aggregates into monomers and forms a complex with TLR4 and the adaptor protein MD-2, 
for initiation of the intracellular signaling cascade leading to NF-kB activation (20, 56). LPS-
NF-kB activation leads to robust increases in inflammatory gene expression including those 
of inflammatory cytokines TNF-a, IL-1b, IL-6, and IL-8 leading to the initiation of local 
inflammation (9, 13, 20). It is worthy of note that THP-1 cells appear more responsive to 
LPS treatment, as indicated by greater increases in phagocytosis and inflammatory cytokine 
secretion, following PMA differentiation (3, 11, 62). Therefore, PMA differentiation 
followed by LPS polarization may lead to consistent M1 polarization and provide a viable 
model of bacterial pathogen exposure prior to systemic immune activation (in the absence of 
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IFN-g from previously activated immune cells) (23). Consequently, I proposed a 3-part 
differentiation and activation protocol in which THP-1 cells were differentiated with PMA 
and then incubated with human serum to simulate in vivo conditions, prior to 
activation/polarization with LPS. In order to optimize responses for utilization of this 
protocol with future human exercise and nutritional interventions, this project involved 3 
stages of optimization: PMA incubation time, LPS incubation concentration, and human 
serum incubation and time. 
Purpose of Study 
 
 Monocytes and Macrophages are multi-functional immune cells with a wide 
distribution and broad impact on the body. The cells are also remarkably plastic by nature 
and, therefore, the factors that influence their function are of great research interest and hold 
potential for profound discoveries. However, study of the dynamics influencing human 
macrophage function in vivo has been limited in the past by technical hurdles. Therefore, the 
purpose of this study was to develop and optimize and procedure for measuring macrophage 
phagocytic function and cytokine secretion in vitro following incubation with human subject 
serum to simulate in vivo conditions.  
Hypothesis 
 
 I hypothesized that shorter PMA incubation times and higher LPS concentrations 
would be associated with greater inductions of phagocytosis and secretion of cytokines IL-
10, TNF-a, IL-1b, and IL-6 from THP-1 monocyte-derived macrophages. I further 
hypothesized that shorter incubation times and higher serum concentrations would be 
associated with the greatest increases in phagocytosis and secreted cytokines, compared to 
longer incubations or lower serum concentrations.  
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Chapter 2: Methods 
Methods 
 
To reiterate, the purpose of this project was to develop and optimize a procedure for 
evaluating the effects of human exercise and dietary interventions on macrophage function in 
vitro, through the incubation of THP-1 monocyte-derived macrophages (MDMs) with human 
serum. In pursuit of this purpose, the project had three aims: 1. Identify the optimal PMA 
differentiation protocol for differentiating THP-1 monocytes to monocyte-derived 
macrophages (MDMs) capable of M1 polarization using LPS. PMA protocols were 
compared based on functional characterization of M1 polarized macrophages using 
assessments of phagocytosis and secreted cytokines. It was the expectation that shorter PMA 
protocols would lead to greater levels of measured phagocytosis and cytokines upon LPS 
polarization.  2. Identify the concentration of LPS that most accurately polarizes THP-1 
MDMs towards the M1 state, without excess stimulation or cytotoxicity. Similar to aim 1, 
LPS concentrations were compared based on measured phagocytosis and cytokine levels of 
polarized MDMs. Additionally, NucBlue staining and fluorescence was used to assess cell 
numbers following polarization. It is expected that both the lowest and highest concentrations 
of LPS will lead to lower levels of phagocytosis and cytokines due insufficient and 
overstimulation of the cells, respectively. However, no differences in cell numbers are 
expected between LPS concentrations as indicated by NucBlue fluorescence. 3. Distinguish 
the optimal human serum concentration and incubation time for incubating THP-1 MDMs 
prior to M1 polarization. Just as in aim 2 the outcome measures used to determine cellular 
responses were phagocytosis, secreted cytokines, and NucBlue fluorescence.  Out of the 
tested conditions, optimal responses in this aim were considered intermediate levels of both 
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phagocytosis and cytokine secretions, without no difference or higher NucBlue fluorescence. 
This is due to the future goals for this procedure, in which both pro-inflammatory and anti-
inflammatory effects the tested human intervention will need to be distinguished. It was 
expected that both higher concentrations, and longer incubation times would be associated 
with greater phagocytic and cytokine responses, and vice versa. The latter three aims formed 
the three stages of the overall study, the methods of which are detailed below. 
THP-1 Culture. THP-1 monocytes were maintained at 37° C and 5% CO2 in THP-1 media  
composed of RPMI-1640 media with 2mM glutamine, supplemented by 10% fetal bovine 
serum and 0.05 mM b-mercaptoethanol. Cell concentration was maintained between 
400,000-1,000,000 cells/mL in a 30 mL culture flask by passaging every 3-5 days. Passaging 
included visual inspection and estimation of culture concentration. For visual inspection cells 
were observed by light microscopy within the culture flask for subjective detection of culture 
contamination or aberrant cell behavior. For estimation of culture concentration, two separate 
200 µL aliquots were removed from the cell culture flask for counting with a hemocytometer. 
Ten microliters (10 µL) of each cell aliquot was mixed with trypan blue at a ratio 1:1, then 
added to the hemocytometer for counting. The cells counted alive and dead from each aliquot 
were averaged and used to calculate the culture concentration and cell viability.  
 
Culture concentration estimated using the formula: 
 
)
(𝑎𝑙𝑖𝑣𝑒	𝑐𝑒𝑙𝑙𝑠	𝑎𝑙𝑖𝑞𝑢𝑜𝑡	1) + (𝑎𝑙𝑖𝑣𝑒	𝑐𝑒𝑙𝑙𝑠	𝑎𝑙𝑖𝑞𝑢𝑜𝑡	2)
2 : × 5000 = 𝐶𝑒𝑙𝑙𝑠/𝑚𝐿 
 
Cell viability was estimated using the formula:  @ABC.DEFG	HEIIJ
ABC.AIKBE	HEIIJ
L × 100 = %	𝐶𝑒𝑙𝑙	𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 
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When the culture concentration reached 800,000-1,000,000 cells/mL, a volume of the culture 
suspension was removed, and fresh THP-1 media was added to return the culture to ~400,000 
cells/mL in 30 mL of THP-1 media. 
Plating and Differentiation. To initiate differentiation of the THP-1 monocytes to M0 
MDMs, cells were plated to 30 wells of a clear bottom 96-well plate at a total volume of 150 
µL/well and a concentration sufficient to yield 100,000 cells/well. For all experiments but the 
PMA incubation optimization, cells were plated in a 6 x 6 format corresponding to four 
experimental rows and one positive control row with 6 replicates per row. THP-1 media only 
was plated to an additional row of 6 to serve as the negative (no cells) control condition.  For 
the PMA incubation optimization experiments, cells were plated in a 6 x 3 format with each 
with row split between two of the incubation conditions, 3 replicates each. THP-1 media only 
was plated to an additional row of 3 to serve as the negative control condition. See Figures 1 
and 2 for a diagram of the plate set-up. Differentiation was only commenced once the cell 
culture reached > 800,000 cells/mL and no more than 1.1 million cells/mL as culture 
conditions have previously been shown to significantly impact differentiation in THP-1 
monocytes (3).  
PMA Differentiation. In order to determine the differentiation protocol which most clearly 
led to M1 polarization 4 different incubation protocols were compared: 96 hr PMA 
incubation (PMA included during 72 hr differentiation period and 24 hr LPS incubation; 
96PMA); 72 hr PMA incubation (PMA removed during 24 hr LPS incubation; 72PMA); 48 
hr PMA with 24 hr “rest” in culture media prior to addition of LPS (48PMA); and 24 hr 
PMA with 48 hr “rest”  prior to addition of LPS (24PMA). In each incubation condition the 
same concentrations  of 25 nM PMA and 0.5 µg/mL LPS were used. LPS treated cells in 
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each condition were compared to “positive control” cells unstimulated by LPS but 
differentiated in the same manner. 
M1 polarization. In order to determine the effect of LPS concentration on THP-1 MDM 
function, four concentrations of LPS (0.1, 0.2, 0.5, 1.0 µg/mL) were tested for their effect on 
phagocytosis and cytokine secretion in M0 THP-1 MDMs. Specifically, following the 72-
hour differentiation protocol outlined above, THP-1 media was removed and replaced with 
THP-1 media plus the addition of 0.1, 0.2, 0.5, or 1.0 µg/mL LPS, or control (no LPS). The 
cells were then incubated with LPS for 24 hours prior to assessment of phagocytosis. The 
media/supernatant following the 24-hour LPS incubation was saved for later assessment of 
secreted cytokines. 
Serum Incubation. In order to determine the effect of concentration and incubation time with 
human serum (HS) on THP-1 MDM function, four concentrations (10%, 25%, 35%, 50% ) of 
HS and five incubation times (0.5, 1.0, 2.0, 3.0, and 4.0 hours) were assessed for their effect 
on phagocytosis and cytokine secretion patterns in THP-1 MDMs subsequently activated 
with 0.5 µg/mL LPS (determined from LPS optimization experiments). Specifically, 
following differentiation to the M0 state (using the previously determined differentiation 
protocol and 25 nM PMA), THP-1 media was removed and replaced with RPMI-1640 media 
+ X% HS or control (10% FBS). The cells were then incubated with HS for the allotted time 
followed by the addition of 0.5 µg/mL LPS to activate towards the M1 polarization state. 
Phagocytosis and cytokine secretion were assessed the same as detailed above (M1 
polarization.) 
Phagocytosis. Phagocytic function of differentiated and/or polarized THP-1 MDMs was 
evaluated using the Vybrant Phagocytosis Assay (Vybrant Phagocytosis Assay Kit, 
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ThermoFisher Scientific). In detail, fluorescein-labeled E. Coli K-12 BioParticles were 
suspended in Hank’s balanced salt solution (HBSS) and diluted in sterile de-ionized water to 
a final concentration of 1 mg BioParticles/1 mL solution. As stated above, the 
media/supernatant following the 24-hour LPS incubation was saved for later assessment of 
secreted cytokines. Then, 100 µL of the Bioparticle solution was added to each of the wells 
and the plate was returned to the incubator for an additional 2-hour incubation to allow for 
cellular Bioparticle consumption (i.e. phagocytosis). At the end of 2 hours, the BioParticle 
solution was removed by vacuum aspiration and replaced with 100 uL of trypan blue to 
quench extracellular BioParticle fluorescence. The plate was incubated with trypan blue for 
one minute before removal by vacuum aspiration and reading on a fluorescent plate reader. 
Plates were read from the bottom with excitation wavelength set to 480 nm and emission 
wavelength set to 520 nm.  
The % effect of the experimental intervention on phagocytosis was calculated using the 
formula below: 
 
𝑁𝑒𝑡	𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙	𝑅𝑒𝑎𝑑𝑖𝑛𝑔
𝑁𝑒𝑡	𝑃𝑜𝑠𝑖𝑡𝑣𝑒	𝑅𝑒𝑎𝑑𝑖𝑛𝑔 × 	100 = %	𝑃ℎ𝑎𝑔𝑜𝑐𝑦𝑡𝑜𝑠𝑖𝑠	𝐸𝑓𝑓𝑒𝑐𝑡 
To assess the qualitative effect of the LPS and HS treatments on cells numbers,  cellular 
DNA content of each well was assessed using NucBlue (NucBlue Live ReadyProbes, 
ThermoFisher Scientific) immediately following the phagocytosis read. Specifically, 100 uL 
of NucBlue solution prepared in 1x PBS was added to each well and incubated at room 
temperature for 15 minutes. The plate was then read again, with an excitation wavelength of 
360 nm and emission set to 460 nm. 
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Cytokines. Pro- and anti-inflammatory cytokines secreted by the cells from select 
experimental conditions were measured using a multiplex, magnetic bead-based assay panel 
(Milliplex, MilliporeSigma, Product #HCYTOMAG60) and fluorescent imaging platform 
(MagPix, Luminex). Specifically, cell culture media/supernatants collected following the 24-
hour LPS incubation and prior to phagocytosis measurement, were screened for the 
concentrations of the anti-inflammatory cytokine IL-10, and the pro-inflammatory cytokines 
IL-1b, IL-6, and TNF-a . These cytokines were assessed to screen for the relative 
polarization state of the macrophages towards an M1 phenotype, with greater secretion of 
pro-inflammatory and lesser secretion of anti-inflammatory cytokines indicating M1 
polarization (36, 64). The results obtained from each intervention were compared to 
appropriate controls to distinguish basal or background cytokine secretion from that elicited 
by the interventions (e.g. LPS, Human serum concentration and incubation time.) Due to 
limited analysis materials, only one well from each experimental condition (e.g. 0.1 µg/mL 
LPS) was analyzed for cytokines. Wells selected for analysis were those closest to the mean 
phagocytosis reading for that condition, in order to determine the cytokine levels that 
approximated the mean response of that condition. In all, 10 samples were analyzed from the 
PMA differentiation experiments (4 conditions + 1 negative control per plate), 6 samples 
were analyzed from the LPS polarization experiments (5 conditions + 1 negative control), 
and 32 samples were analyzed from the serum incubation experiments (5 conditions + 1 
negative control per time point, 1 sample each of control media and 50% HS media.) 
Statistical Analysis. Phagocytosis data from the PMA (3 replicates each condition) and LPS 
(6 replicates each condition) optimizations were analyzed using a one-way analysis of 
variance (ANOVA) with an alpha level set to p= 0.05 to assess the effect of time and 
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concentration, respectively. Phagocytosis and NucBlue data from the Human serum 
optimization experiments (6 replicates each condition) were analyzed using a one-way 
ANOVA to assess the effect of serum concentration at each time-point (e.g. 1.0 hr 
incubation), the effect of concentration across incubation times, and the effect of incubation 
time across concentrations.  Additionally, a two-way ANOVA was used address time x 
concentration effects. Following significant F-ratios, Bonferroni post-hoc analyses were 
performed to detect specific treatment condition effects.  As with analysis of the PMA and 
LPS optimizations, the alpha value for both the human serum one-way and two-way 
ANOVA were both set 𝑝 = 0.05. SPSS Statistics (IBM Corp.) was used for all statistical 
analyses. No statistical analyses were performed for the inflammatory cytokine assessments 
due to the selection of specific single wells for any given treatment condition per experiment. 
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Chapter 3: Results 
 
PMA Differentiation. To determine the differentiation protocol which most clearly led to M1 
polarization following differentiation and 24 hours incubation with 0.5 µg/mL LPS, 4 
differentiation protocols (96PMA, 72PMA, 48PMA, 24PMA) were compared as detailed 
above in Methods. In each incubation condition the same concentration of 25 nM PMA was 
used. LPS treated cells in each condition were compared to “positive control” cells 
unstimulated by LPS but differentiated in the same manner. 
Phagocytosis Data 
 
48PMA led to a mean increase in phagocytosis of 774 ± 282% relative to positive controls. 
This is compared to 379 ± 79% with 24PMA, 42 ± 3% with 96PMA, and 13 ± 5% with 
72PMA. Analysis of the data with a one-way ANOVA revealed there to be a significant 
effect of incubation time on phagocytosis (𝑝 < 0.01). Post-hoc tests using Bonferroni 
Correction showed the increase in phagocytosis with 48PMA to be significantly greater than 
either 96PMA or 72PMA (𝑝 < 0.01 for both), with a trend toward a significant difference 
between 48PMA and 24PMA (𝑝 = 0.065). The data are summarized in Figure 3. 
Cytokine Data 
 
Following differentiation, a 24-hour incubation with 0.5 µg/mL LPS increased levels of all 
measured cytokines (IL-10, IL-1b, TNF-a, IL-6), as compared to control (no LPS). 
Unfortunately, due to technical complications, cytokine data from 96PMA were lost during 
analysis. Of the three remaining conditions, 24PMA consistently led to the highest levels all 
cytokines. 48PMA led to the second highest concentrations of IL-10, TNF-a, and IL-6. 
While 72PMA led the second highest level of IL-1b and the lowest recorded levels of IL-10, 
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TNF-a, and IL-6. Cytokine data from one sample of each PMA condition are displayed in 
Figure 4. 
LPS Concentration. Following the results of the preliminary PMA incubation studies, the 
48PMA incubation protocol was chosen for the remainder of the optimizations of both LPS 
concentration and human serum incubation/concentration. This decision was made due to the 
high level of LPS-induced phagocytosis and pro-inflammatory cytokines, yet lower anti-
inflammatory cytokines associated with the 48PMA condition. Next, to determine the 
optimal LPS concentration for polarizing PMA-differentiated THP-1 MDMs to the M1 
polarization state, 4 different LPS concentrations (0.1, 0.2, 0.5, and 1.0 µg/mL) were 
compared for their effect on phagocytosis and cytokine secretion patterns. 
Phagocytosis Data 
 
The four LPS concentrations led to mean increase in phagocytosis of 350 ± 85% relative to 
unstimulated cells. By condition, 0.5 µg/mL led to an increase of 395 ± 102%, 0.2 µg/mL led 
to a 352 ± 43% increase, 0.1 µg/mL led to a 345 ± 116% increase, and 1.0 µg/mL led to a 
307 ± 55% increase relative to cells unstimulated by LPS. Despite these absolute differences, 
analysis of the data with a one-way ANOVA showed there to be no significant effect of LPS 
concentration on phagocytosis (𝑝 = 0.386). The data are summarized in Figure 5. 
Cytokine Data 
 
Following differentiation to MDMs, 24 hr of incubation with all four concentrations of LPS 
led increased levels of each of the measured cytokines relative to unstimulated cells. 
Incubation with 0.5 µg/mL LPS led to the greatest increase in IL-10, while 1.0 µg/mL LPS 
led to the greatest increase in TNF-a and IL-6. The 0.1 µg/mL LPS treatment led to the 
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lowest levels of IL-1b with the other three concentrations showing similar responses. 
Cytokine data from one sample of each LPS concentration are displayed in Figure 6. 
NucBlue Cellular DNA 
 
To test for a differential effect of LPS concentration on cellular DNA, immediately following 
the assessment of phagocytosis all wells were treated with NucBlue and the plate was read 
again at an emission and excitation of 360 and 460 nm, respectively. The results indicated a 
significant effect of condition on NucBlue fluorescence (𝑝 < 0.01). Post-hoc analysis using a 
Bonferroni Correction revealed that the 0.1, 0.2, and 0.5 µg/mL LPS conditions led to 
significantly higher NucBlue fluorescence than the positive control, non-LPS treated 
condition (𝑝 < 0.05, 𝑝 < 0.05, 𝑝 < 0.01 respectively.) There was also a trend for higher 
NucBlue fluorescence in the 1.0 µg/mL LPS condition than the positive control condition 
(𝑝 = 0.065). There were no significant differences observed between concentrations (𝑝 =
1.000 for all). The latter data are summarized in Figure 7. 
Summary 
 
Although statistically significant differences were not observed between the four tested LPS 
concentrations, it was decided that 0.5 µg/mL LPS would be used in the remaining human 
serum (HS) optimizations. This decision was made as 0.5 µg/mL LPS led to the greatest 
absolute increase in phagocytosis, similar levels of cytokine secretion, and would lend 
consistency to the experiments, given that this concentration was used during the PMA 
optimization as well. 
Human Serum Incubation and Concentration. To examine the effect of human serum (HS) 
concentration in the incubation media and incubation time on THP-1 MDM function, 4 
different concentrations of HS were tested across 5 different incubation times as detailed in 
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the “Methods” section. Phagocytosis data are detailed by incubation time below, followed by 
cytokine data. 
Phagocytosis Data - 0.5 hr HS Incubation 
 
Following 0.5 hr of incubation, phagocytosis increased to 164 ± 60% with 10% HS media, 
186 ± 126% with 25% HS media, 298 ± 153% with 35% HS media, and 290 ± 121% with 
50% HS media relative to positive control cells incubated with 10% FBS. Analysis of the 
data (6 replicates per condition) with a one-way ANOVA indicated there was no significant 
effect of HS concentration on phagocytosis (𝑝 = 0.143). Phagocytosis data for 0.5 hr HS 
incubation are summarized in Figure 7. 
Phagocytosis Data - 1.0 hr HS Incubation 
 
Following 1.0 hr of incubation, phagocytosis increased to 150 ± 37% with 10% HS media, 
209 ± 31% with 25% HS media, 236 ± 50% with 35% HS media, and 162 ± 20% with 50% 
HS media relative to positive control cells incubated with 10% FBS. Analysis of the data 
with a one-way ANOVA indicated there was a significant effect of HS concentration on 
phagocytosis (𝑝 < 0.01). Post-hoc tests using Bonferroni Correction showed the increase in 
phagocytosis observed with 35% HS was significantly greater than either 10% or 50% 
conditions (𝑝 < 0.01 and 𝑝 < 0.05 respectively), and there was trend for 25% HS to be 
greater than the 10% HS condition (𝑝 = 0.062). There were no significant differences 
observed between the 25% and 35%, or 10% and 50% HS conditions (𝑝 = 1.000 for the 
latter pairwise comparisons.) Phagocytosis data for 1.0 hr HS incubation are summarized in 
Figure 8. 
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Phagocytosis Data - 2.0 hr HS Incubation 
 
2.0 hr of HS incubation led to a phagocytosis effect of 98 ± 43% with 10% HS media, 133 ± 
30% with 25% HS media, 155 ± 94% with 35% HS media, and 249 ± 108% with 50% HS 
media relative to positive control cells incubated with 10% FBS. Analysis of the data with a 
one-way ANOVA indicated there was a significant effect of HS concentration on 
phagocytosis (𝑝 < 0.05). Post-hoc tests using Bonferroni Correction showed the increase in 
phagocytosis observed with 50% HS was significantly greater than 10%, but not 25% or 35% 
(𝑝 < 0.01, 𝑝 = 0.092, and 𝑝 = 0.267, respectively). There were no significant differences 
observed between the 10%, 25%, or 35% conditions (𝑝 = 	1.000). Phagocytosis data for 2.0 
hr HS incubation are summarized in Figure 9. 
Phagocytosis Data - 3.0 hr HS Incubation 
 
3.0 hr of HS incubation led to a phagocytosis effect of  46 ± 16% with 10% HS media, 123 ± 
25% with 25% HS media, 116 ± 20% with 35% HS media, and 121 ± 20% with 50% HS 
media relative to positive control cells incubated with 10% FBS. Analysis of the data with a 
one-way ANOVA indicated there was a significant effect of HS concentration on 
phagocytosis (𝑝 < 0.001). Post-hoc tests using Bonferroni Correction showed the increase in 
phagocytosis observed with 25%, 35%, and 50% HS was significantly greater than the 10% 
HS condition (𝑝 < 0.001 for all). There were no significant differences observed between 
25%, 35%, or 50% conditions (𝑝 = 1.000). Phagocytosis data for 3.0 hr HS incubation are 
summarized in Figure 11. 
Phagocytosis Data - 4.0 hr HS Incubation 
 
4.0 hr of HS incubation led to a phagocytosis effect of 85 ±2 8% with 10% HS media, 
86±29% with 25% HS media, 143 ± 34% with 35% HS media, and 105 ± 30% with 50% HS 
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media relative to positive control cells incubated with 10% FBS. Analysis of the data with a 
one-way ANOVA indicated there was a significant effect of HS concentration on 
phagocytosis (𝑝 < 0.05). Post-hoc tests using Bonferroni Correction showed the increase in 
phagocytosis observed with 35% HS was significantly greater than 10% HS or 25% HS, but 
not 50% HS (𝑝 < 0.05, 𝑝 = 0.342 respectively). There were no significant differences 
observed between the 10%, 25%, or 50% conditions (𝑝 = 	1.000). Phagocytosis data for 4.0 
hr HS incubation are summarized in Figure 11. 
Effect of Time by Concentration 
 
As opposed to the effects of concentration at each time point (e.g. 25% HS at 2.0 hr) as 
detailed above, it was also of interest to evaluate the effect of incubation time across 
concentrations (i.e. overall effect of 1.0 hr vs. 2.0 hr), concentration across incubation times 
(i.e. overall effect of 10% vs. 35% HS), as well as if there was a combined effect of 
concentration by time on phagocytosis (i.e. 25% at 2.0 hr vs 10% at 1.0 hr). A two-way 
ANOVA was used to analyze the latter question. The results indicated that while there was 
only a trend towards a significant interaction effect of human serum concentration by time 
(𝑝 = 0.059), there was a significant main effect of concentration (𝑝 < 0.001), as well as a 
significant main effect of time (𝑝 < 0.001). One-way ANOVA for the effect of 
concentration over time indicated a significant main effect of concentration (𝑝 < 0.01). Post-
hoc tests using Bonferroni Correction showed the increase in phagocytosis with 35% and 
50% HS across incubation times was significantly greater than that with 10% (190 ± 105% 
and 188 ± 102% vs 109 ± 57% respectively;  𝑝 < 0.01 for both). There were no significant 
differences observed between 10% and 25% (𝑝 = 0.513), 25% and either 35% or 50% (𝑝 =
0.363 and 𝑝 = 0.421, respectively), or 35% and 50% (𝑝 = 1.000). One-way ANOVA 
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examining the effect of incubation time across concentrations indicated a significant main 
effect of incubation time (𝑝 < 0.001). Post-hoc tests using Bonferroni Correction showed the 
increase in phagocytosis observed with 0.5 hr incubation across concentrations (234 ± 128%) 
was significantly greater than 2.0 hr (159 ± 91%; 𝑝 < 0.05), 3.0 hr (101 ± 38%; 𝑝 < 0.001), 
or 4.0 hr (105 ± 37%; 𝑝 < 0.001). Additionally, phagocytosis with 1.0 hr incubation was 
significantly greater than either 3.0 hr or 4.0 hr (𝑝 < 0.01 for both). No significant 
differences were observed between 2.0, 3.0, or 4.0 hr incubation times (𝑝 = 0.118, 𝑝 =
0.183, and 𝑝 = 1.000, respectively). Data for the effect of time and concentration are 
summarized in Figures 12 and 13. 
Cytokine Data 
Two general trends emerged in analyzing the secreted cytokine levels from the human serum 
optimization experiments. For the cytokines IL-10, TNF-a, and IL-6, increasing incubation 
times were associated with lower cytokine levels. In contrast,  IL-1b levels appeared to 
remain relatively consistent across incubation times, at a given concentration. Following the 
former trend, IL-10 levels were highest in the 50% HS conditions with 0.5 and 1.0 hr 
incubations. Similarly high levels of IL-10 were also observed in the positive control 
condition (10% FBS) with 3.0 hr incubation. The highest TNF-a levels were observed in the 
10% HS condition with 0.5 hr incubation. In regard to IL-1b, the highest levels were 
observed in the 50% HS condition with peaks at both 1.0 and 3.0 hr incubation. With the 
exception of a low value at 1.0 hr incubation, the highest IL-6 levels were observed in the 
positive control (10% FBS) condition across incubation times. Although, following the larger 
trend, IL-6 levels still tended to fall as incubation time lengthened in the positive control 
condition. Negative control wells containing THP-1 media, but not cells, showed minimal 
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levels of all cytokines across all incubation times, compared to the HS or positive control 
conditions. 
To account for background cytokine levels in the incubation media that might skew 
the latter results, both the THP-1 culture media and the 50% HS media (RPMI-1640 + 50% 
HS by volume) were analyzed and compared for their respective cytokine levels. 
Interestingly, the 50% HS media displayed markedly higher levels of all measured cytokines 
except IL-1b. Conversely, higher levels of IL-1b were observed in the THP-1 culture media, 
although the magnitude of difference was not as great (0.56 vs. 0.43 pg/mL). Nevertheless, 
these background levels were unlikely to meaningfully skew the results of the incubation 
experiments as the concentrations of the former were at least one order of magnitude lower 
than the latter. Cytokine data from both the HS incubation experiments and the incubation 
media are displayed below in Figures 15-19. 
NucBlue Cellular DNA 
To test for a differential effect of HS concentration and incubation time on cellular DNA, 
following assessment of phagocytosis all wells were treated with NucBlue and the plates 
were read again at an emission and excitation of 360 and 460 nm, respectively. The results 
indicated no significant effect of HS concentration or FBS at any single incubation time (𝑝 =
0.239 at 0.5 hr, 𝑝 = 0.525 at 1.0 hr, 𝑝 = 0.354 at 2.0 hr, 𝑝 = 0.399 at 3.0 hr, 𝑝 = 0.202 at 
4.0 hr.) Additionally, there was no significant effect of concentration across incubation times 
or a concentration by time effect (𝑝 = 0.658, 𝑝 = 0.404 respectively.) However, there was a 
significant effect of incubation time across concentrations (𝑝 < 0.001). Post-hoc analysis 
using a Bonferroni Correction revealed the 2.0 (56 5± 77MFI) and 3.0 hr conditions (537 ± 
48 MFI) were not significantly different from one another (𝑝 = 0.549), but both incubation 
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times led to significantly higher readings than all other conditions (0.5 hr, 340.5 ± 54.8 MFI; 
1.0 hr, 469 ± 48 MFI; 4.0 hr, 446 ± 50 MFI, 𝑝 < 0.001 for all).  Additionally, 1.0 and 4.0 hr 
conditions led to significantly higher readings than 0.5 hr (𝑝 < 0.001) but were not different 
from one another (𝑝 = 1.000). The latter data are summarized in Figure 20. 
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Chapter 4: Discussion and Conclusions 
 
Discussion 
 
 The purpose of this project was to develop and optimize a procedure for evaluating 
the effects of human exercise and dietary interventions on macrophage function in vitro. It 
was necessary to create such a procedure because of the widespread and integral role 
monocytes and macrophages (MMs) play in physiological homeostasis (83). MM function 
and plasticity profoundly impact the balance of health and disease, however difficulties with 
isolation and maintenance of human primary cells restricts their broad application (11, 41). 
Previously, animal models and in vitro studies using both animal and human cell lines have 
been the primary means for exploring MM biology (11, 24, 79). Though these studies have 
produced important findings, differences do exist between murine and human MMs as well 
as signaling in vitro versus in vivo (5, 27). Therefore, it is important to explore changes in 
human MM in as close an approximation to in vivo conditions as possible. To serve this 
purpose, it would be advantageous to create a hybrid scheme for leveraging the utility of in 
vitro experiments while simulating in vivo conditions. To accomplish this goal, the current 
project had 3 aims: 1. Establish a PMA differentiation protocol to differentiate THP-1 cells to 
monocyte-derived macrophages (MDMs) capable of M1 polarization using LPS; 2. Identify 
the concentration of LPS that adequately polarized THP-1 MDMs towards the M1 state 
without excess stimulation or cytotoxicity; 3. Identify the human serum concentration and 
incubation time that induces an intermediate THP-1 MDM phenotype in which both pro-
inflammatory and anti-inflammatory effects of future studies might be distinguished. A 
separate set of experiments was carried out to accomplish each aim, in the order listed. 
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PMA Optimization. The results of the PMA optimization showed that 48 hours of incubation 
with 25 nM PMA followed by 24 hours of “rest” in culture media (48PMA) led to the largest 
magnitude of increase in phagocytosis following 24 hours incubation with LPS, as compared 
to cells untreated with LPS (Figure 3). 24-hours of PMA incubation followed by 48 hours of 
rest (24PMA) prior to LPS led to an increase in phagocytosis about half that of the 48-hour 
incubation, while 96- and 72-hour PMA incubations (96PMA, 72PMA) actually led to a 
depression in phagocytosis relative to untreated cells. The reason for the latter results with 
96PMA and 72PMA may have to do with similarities in PMA and LPS inflammatory 
signaling. PMA activates diacylglycerol signaling in monocytes, activating kinases in the 
protein kinase C (PKC) family and leading to cell differentiation (62). In conjunction with 
these effects, PMA also increases inflammatory gene expression including the cytokines IL-8 
and TNF-a, and excess exposure to these cytokines may make cells less stress tolerant and 
prone to cell death (40, 50). Although we did not quantify cell viability in this portion of the 
study, it is possible that the prolonged incubation with PMA and/or the addition of LPS 
induced apoptosis of the cells, leading to lower measured levels of both phagocytosis and all 
cytokines.  
In regard to cytokine levels, unfortunately, complications during sample analysis 
meant that the data on cytokine levels from 96PMA were lost. Concerning the other three 
conditions, 72PMA did display lower levels of all secreted cytokines except IL-1b (Figure 
4). Interestingly, although 48PMA led to the greatest increase in phagocytosis, 24PMA 
displayed the highest levels of all analyzed cytokines. This was particularly true of IL-10 
where the levels observed in 24PMA were more than 3- and 6-fold higher than the levels 
observed in 48PMA and 72PMA, respectively. Given the limited data set that was available 
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for analysis of cytokine levels, it is hard to speculate on the discrepancy between the trends 
observed in the phagocytosis and cytokine data. However, it’s possible the robust secretion 
of cytokines, particularly IL-10, in 24PMA may have had an inhibitory effect on 
phagocytosis by the time it was measured following 24-hour LPS incubation. Cytokines have 
the capacity to signal in both a paracrine and autocrine manner, with the potential to create 
either positive of negative feedback loops for inflammation (23).  It has been shown that Th-
2 cytokines (e.g. IL-4) may actually have an inhibitory effect on phagocytosis yet may not 
affect the secretion of pro-inflammatory cytokines (60, 72). In contrast, it has been shown 
pro-inflammatory cytokines both potentiate and rely upon phagocytosis for their secretion 
(14, 29, 35, 51, 63) . The pro-inflammatory cytokines IL-6, IL-18, and TNF-a have been 
shown to increase phagocytic activity of macrophages (14, 35). Additionally, the act of 
phagocytosis of various target cells has been shown increase release IL-6, TNF-a, and IL-23; 
with TNF-a released directly from the phagocytic cup (29, 51, 63). Though IL-4 was not 
specifically quantified in the current study, the high levels of the anti-inflammatory IL-10 
observed with 24PMA may reflect unmeasured levels of Th2 cytokines leading to the relative 
depression in phagocytosis. Alternatively, even in the absence of other anti-inflammatory 
cytokines, the high levels of IL-10 combined with the high levels of pro-inflammatory 
cytokines could have initiated deactivation or repolarization of the macrophages by the time 
phagocytosis was measured 24 hr later, through compensatory auto- and paracrine signaling 
(23, 64). In contrast, the marked induction of phagocytosis observed in 48PMA was 
associated with moderate levels of the measured cytokines, compared to the other conditions. 
This lends support towards the hypothesized relationship between phagocytosis and 
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cytokines in the 24PMA condition, as the levels of cytokines in 48PMA may have remained 
below the threshold leading to inhibition of phagocytosis.  
In light of the significant increase in phagocytosis observed in 48PMA, the decreases 
observed with 96PMA and 72PMA, and the somewhat contradictory results in 24PMA, the 
48PMA differentiation protocol was chosen for the subsequent aims. Again, the purpose of 
this aim was to identify the PMA differentiation protocol that most reliably led to M1 
differentiation following exposure to LPS. M1 polarization by LPS is characterized by 
enhanced phagocytic capacity, robust secretion of pro-inflammatory cytokines, and lesser 
secretion of anti-inflammatory cytokines (36, 64, 82). It was concluded that the results in 
48PMA best matched the latter criteria and supported the choice of 48PMA going forward. 
LPS Optimization. Similar to the PMA optimization, it was the goal the second aim of the 
study to identify the concentration of LPS that best led to M1 polarization following 
differentiation of THP-1 monocytes to monocyte-derived macrophages with PMA. To 
accomplish this aim four different concentration of LPS were evaluated: 0.1, 0.2, 0.5 and 1.0 
µg/mL. These concentrations were chosen based on a review of the literature for ranges of 
LPS used in macrophage activation (9, 10, 31, 77, 78). The results of this aim revealed that 
all four concentrations of LPS led to >3-fold increase in phagocytosis relative to cells 
untreated with LPS (Figure 5). Of the four, 0.5 µg/mL LPS led to the greatest increase in 
phagocytosis (394.5 ± 102.4%). Although, the latter result was not statistically different from 
the other conditions. Perplexingly, the latter increase in phagocytosis was less than that 
observed using the same LPS concentration in the PMA optimization experiments (395 ± 
102% vs. 774 ± 282%). It is unclear why this difference occurred. Parallel to the 
phagocytosis results, all four LPS concentrations led to relatively similar cytokine responses 
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with the exception of IL-1b (Figure 6). 0.2, 0.5, and 1.0 µg/mL conditions all led to IL-1b 
concentrations of ~280 pg/mL while 0.1 µg/mL led to a concentration of 193 pg/mL. 
However, due to limited samples available for analysis, it was not possible to determine 
whether the latter difference was indicative of real response or sample variability. 
 In order to address the potential effect of LPS concentration on cell number, that 
might affect both phagocytosis and cytokine results, NucBlue was added to stain for cellular 
DNA following the phagocytosis readings and the plate was read again at the applicable 
excitation and emission wavelengths. The results of this experiment indicated that the 
application of LPS may have led to better maintenance of cell numbers, as all LPS conditions 
led to significantly higher readings than the positive control condition. Furthermore, there 
were no significant differences observed between LPS conditions. Though this result was 
surprising, it did mean that LPS was not differentially affecting cell numbers between 
concentration, and differences in the primary outcomes measures were due to responses of 
the cells specifically to LPS concentration rather than differences in cell numbers. 
 Considering the lack of significant differences observed in the phagocytosis data, and 
the relatively equivocal results between the three higher LPS conditions, it was decided that 
0.5 µg/mL would be used as the M1 polarizing stimulus in aim 3. The rationale behind this 
decision was 3-fold: 1. Though not statistically significant, 0.5 µg/mL did lead to the greatest 
increase in phagocytosis of the four concentration; 2. Since it was the LPS concentration also 
used in aim 1, continuing to use 0.5 µg/mL in aim 3 would maintain consistency of the 
stimulus across the 3 aims; and 3. Previous work by another lab concluded that 0.7 µg/mL 
LPS led to similar inflammatory gene expression patterns as 1.0 µg/mL, but lower magnitude 
changes such that the effect of additional polarization modulating substances (e.g. serum) 
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might be more easily observed (10). Since it was the goal of the foregoing serum 
optimizations to be able to observe additional modulation of macrophage phenotype with 
human serum, it was decided that 0.5 µg/mL was the optimal concentration in which to 
proceed. 
Human Serum Optimization. With the ultimate goal of utilizing these optimized procedures 
in future studies in which the imposed human intervention would be the main variable of 
interest, this aim set out to identify the ideal HS concentration and incubation time that would 
yield a macrophage phenotype in which both depressions and enhancements in the 
inflammatory response might be observable. Previous research has shown that acute exercise 
can increase, while chronic physical exertion and stress can decrease macrophage function 
(18, 66). Similarly, dietary compounds have the potential to both increase or decrease the 
inflammatory responses of macrophages (9, 17, 67). Considering the human serum used for 
this study was from a resting subject not currently undergoing any specific training program 
or undertaking a special diet, maximal or minimal responses to LPS following serum 
incubation would limit future applications of this procedure. It was important to keep the 
latter purpose in mind when contextualizing the results of this aim. 
 In comparing the mean effect on phagocytosis of the four concentrations of human 
serum across incubation times, the 35% and 50% human serum concentrations both led to 
more significant inductions of phagocytosis with LPS than the 10% human serum condition 
(Figure 12) . Furthermore, 35% and 50% human serum conditions also led to, on average, 
greater induction of phagocytosis than 25% human serum, though this was not statistically 
significant. These results were supported by the observation that 35% HS led to the highest 
phagocytosis induction following 0.5, 1.0, and 4.0 hr incubation while 50% HS led to the 
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highest phagocytosis induction following 2.0 hr HS (Figures 7, 8, 9, 11). Technically, 25% 
HS led to the highest induction of phagocytosis following 3.0 hr incubation (Figure 10). 
Although, the difference between 25% and 35% or 50% at 3.0 hr was minor (123 ± 25% with 
25% HS vs. 116 ± 20% with 35% HS, and 121 ± 20% with 50% HS.) 
 In contrast, the longer incubation times were associated with smaller mean inductions 
of phagocytosis with LPS. Phagocytosis induced following 3.0 and 4.0 hr HS incubation was 
significantly less than after 0.5 hr incubation, but not significantly different from 2.0 hr 
incubation (Figure 13). Further, there was no significant difference observed between the two 
longer incubations. This suggests that the initial exposure to new media may make the cells 
more prone to LPS induced phagocytosis, and that longer exposure to HS leads to an 
attenuation of the response to LPS. Similar trends were observed in the cytokine data. 
 Unfortunately, due to limited resources, only a restricted sample of the HS data was 
able to be analyzed for cytokine levels. As a result of this limited sample, it is difficult to 
make broad conclusions about the cytokine responses of the different treatments and whether 
outlying values are in fact that, or if they reflect a real trend. Nevertheless, some interesting 
relationships were observed in the data. Though less dramatic than the reduction in induced 
phagocytosis, in general, longer HS incubation times were associated with lower secreted 
cytokines following 24 hr incubation with LPS (Figures 14-17). This trend held true across 
HS concentrations and the positive control condition, although was most notable in regard to 
the levels of IL-10 and TNF-a. The latter results may point towards the addition of HS as a 
potentially stressful event that potentiates both cytokine release and phagocytosis upon the 
addition of LPS. Conversely, increasing HS concentration was associated with greater IL-10 
and IL-1b secretion but reduced TNF-a and IL-6 secretion. It is also noteworthy that the 
 53 
highest levels of IL-6 across incubation times were observed in the positive control 
condition. The conflicting trends of increasing IL-10 and IL-1b but decreasing TNF-a and 
IL-6 levels with higher serum concentration are difficult to reconcile. However, they may 
point towards either reciprocal relationships between IL-10/IL-1b and TNF-a/IL-6 (i.e. 
increasing IL-10 decreases TNF-a) or mirror relationships between IL-10 and IL-1b, and 
TNF-a and IL-6. Previously, it has been shown that IL-6 infusion at levels similar to those 
observed during exercise potentiates the release of IL-10, IL-1ra, and cortisol in humans (68). 
If a similar relationship were observed here, it would have been expected that the peak levels 
of IL-6 observed with the positive control treatment would have led to commensurately high 
levels of IL-10. However, this was not the case. The differences between the IL-6:IL-10 
relationship in the current study and the latter one may be explained by the source of the 
cytokines. Cytokines in the latter study were isolated from the systemic circulation, meaning 
that they could be derived from multiple cell populations and tissue compartments. In 
contrast, the cytokines in the current study were solely MDM derived.  It would be 
interesting to explore the relationships in cytokine signaling between macrophages 
themselves, as well as macrophages and different tissue/cell types in the future. This is 
worthy of additional investigation. 
 In order to address the potential effect of LPS concentration on cell numbers, that 
might affect both phagocytosis and cytokine results, NucBlue was added to stain for cellular 
DNA following the phagocytosis readings and the plate was read again at the applicable 
excitation and emission wavelengths. The result of this portion of the experiments revealed 
no significant effect of HS concentration or the positive control condition on NucBlue 
fluorescence at any specific incubation time or across incubation times. Additionally, there 
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was no significant effect of concentration by time on NucBlue fluorescence. However, there 
was a significant effect of time across concentrations such that all higher incubation times led 
to significantly higher NucBlue fluorescence than at 0.5 hr Additionally, 2.0 and 3.0 hr led to 
higher readings than 1.0 and 4.0 hr. Comparing this information to the phagocytosis and 
cytokine data, it would appear that higher NucBlue readings were associated with lower 
phagocytosis and cytokine levels. This relationship lends support to the hypothesis that the 
addition of HS is stressful to the cells and may concurrently lead to heightened inflammatory 
responses and decreased cell numbers. Contradicting this hypothesis is the fact the positive 
control condition containing FBS, not HS, led to consistently lower NucBlue readings, 
though none of these differences were statistically significant. If the HS was negatively 
affecting cell numbers, it would be expected that the FBS condition would have led to higher 
readings, particularly at the shorter incubation times. However, this was not the case. 
Taken together, the results of the HS optimization experiments (aim 3) point towards 
an attenuation of LPS response with increasing incubation time and heightened responses 
with increasing serum concentration. Given the goals of this aim was to define conditions 
that lead to an intermediate response in THP-1 MDMs, it was concluded that 3 hr incubation 
and 35% HS are the optimal conditions for HS exposure prior to LPS polarization. This 
decision was made given the plateau in phagocytosis responses starting at 3 hr. incubation 
and 35% HS in the context of time and concentration, as well as the intermediate cytokine 
responses observed with the same time/concentrations. Although both 25% and 50% HS led 
to similar phagocytosis responses as 35% at 3.0 hr incubation, the cytokine responses were 
either higher or lower than 35% HS. Therefore, the choice of 35% HS gives a better chance 
at observing higher or lower responses to LPS in future investigations. In regard to time, 4.0 
 55 
hr incubation led to similar phagocytosis responses as 3.0 hr overall. However, the cytokine 
responses were reduced relative to 3.0 hr incubation and may diminish the ability to observe 
decreases in cytokine response to LPS with additional variables. Hence, 3.0 hr incubation 
was deemed the more prudent option.   
Conclusions and Future Directions 
To reiterate, the overall goal of this project was to develop an experimental procedure 
for the measurement of in vitro THP-1 MDM function following incubation with human 
serum to simulate in vivo conditions. In regard to the three specific aims of the project, it was 
determined that: 1. Of the tested protocols, the optimal PMA-differentiation scheme involved 
48 hr incubation with 25 nM PMA followed by 24 hr “rest” prior to LPS exposure; 2. 
Though not significantly different from the other conditions, 0.5 µg/mL LPS may provide a 
“happy medium” of M1 polarization without overstimulating the cells; 3. 35% human serum 
concentration for 3.0 hr incubation provides the best chance at capturing increased or 
decreased MDM responses to LPS in future investigations. In summary, based on the current 
results it is recommended that THP-1 monocytes be differentiated to M0 macrophages with 
25 nM PMA for 48 hr, followed by 24 hr “rest” in culture media. It is then recommended that 
differentiated THP-1 MDMs be incubated with human subject serum at a concentration of 
35% for 3.0 hours, prior to exposure to 0.5 µg/mL LPS for a further 24 hr incubation. This 
procedure should reliably afford adequate stimulus to polarize THP-1 MDMs towards the M1 
state and allow for examination of the modulating effect of soluble factors in human subject 
serum upon the latter phenotype. To build on this scheme, future investigations should 
evaluate whether the same differentiation and serum incubation conditions are amenable to 
M2 polarization with IL-4 or IL-13. Furthermore, LPS alone was chosen as the M1 
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polarizing stimulus in this study for simplicity, and to model primary responses to bacterial 
infection. However, IFN-g is also a potent M1 polarizing compound and frequently used in 
conjunction with LPS to polarize THP-1 cells towards the M1 state (9, 23, 65). It would be 
interesting to examine to what degree treatment with a combination of IFN-g + LPS might 
alter cell responses in the current procedure. Additionally, it is possible that M1 polarization 
using LPS or IFN-g + LPS may not be applicable to all research questions. The LPS stimulus 
was chosen for this experiment as it was the goal to expand on the commonly used steps of 
THP-1 differentiation and polarization with the addition of serum incubation, and model 
macrophage responses to initial bacterial stimulus (23, 56). By modifying an existing 
paradigm, it was the aim to facilitate comparisons between previous studies and the changes 
observed with serum incubation. However, for studies evaluating changes in the 
inflammatory response to acute exercise LPS polarization is not applicable. In the latter case 
the current procedure would likely need to be modified by the measurement of phagocytosis 
and cytokines immediately following serum incubation, with no polarization step. Then, 
comparisons could be made between the effects of serum at different timepoints around 
exercise (pre-, intra-, post-) and due to the variable of interest.  Along the same lines, within 
the current procedure, analysis of phagocytosis and cytokine secretion following each step of 
the procedure (e.g. PMA differentiation) would allow for the determination of changes in 
macrophage function with each step, and more accurate identification of when (and perhaps 
why) changes are occurring. Finally, in light of the important role that macrophage plasticity 
appears to play in health vs. disease, it is of interest whether serum incubation following 
MDM polarization (rather than before it) might modify or re-polarize the cells. Both exercise 
training and food derived compounds have shown evidence of modulating MM polarization 
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and phenotype, and it is possible re-polarization of activated macrophages could be the 
mechanism (9, 22, 70). The latter additions would expand the applications of the current 
procedure and the translation of its results. Consequently, though the results of this study 
outline a useable framework for assessing in vitro MDM function following human serum 
incubation, more work is needed to enhance the procedure’s usefulness and impact. 
With the recognition that additional experiments may be necessary to fully optimize 
the recommended procedure, some limitation of the current study also need to be 
acknowledged. First of all, due to time and resource constraints, replicate experiments under 
each aim were limited. This means that the long-term repeatability of the procedure is 
unknown and in addition, limited data points may have hampered the statistical significance 
of some of the results. In particular there were trends towards a significant effect of HS 
concentration x incubation time (𝑝 = 0.059), as well as a significant difference between 
48PMA and 24PMA (𝑝 = 0.065). It is possible that additional data points would push the 
latter relationships towards statistical significance, although they might not change the 
conclusions of the project. Furthermore, due to the same constraints, only a small selection of 
samples from each condition was used for cytokine analysis. This meant that statistical 
analysis of trends in the data was not possible and restricts the conclusions that can be drawn. 
So, in addition to the added experiments outlined in the previous paragraph, it is 
recommended that each aim be repeated to confirm the results reported here. Finally, the lack 
of significant differences between concentrations in the LPS optimization (aim 2) could have 
been due to an inappropriate incubation time rather than, or in conjunction with, inadequate 
data points. The 24-hour incubation time was chosen as this was previously shown to be 
when cytokine secretion peaked or plateaued in LPS stimulated THP-1 MDMs (10). 
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However, it may have been advisable to use a shorter incubation time to examine the 
cytokines while they were ascending to their peak, and the rate of change was highest. 
Furthermore, cytokine kinetics and phagocytosis may operate on different time scales and the 
ideal time to measure phagocytosis post-LPS exposure could be different than that of 
cytokine secretion. It is recommended that future experiments explore this question. 
Summary. Monocytes and macrophages are omnipresent throughout the body, serving a 
plethora of auxiliary functions in pathogen detection, metabolism, and organ homeostasis 
(83). Consequently, the diversity, character, and plasticity of monocytes and macrophages 
has a profound impact on organismal development, disease risk, and aging (65). Despite their 
importance, relatively little is known about the factors that influence transitions in monocyte 
and macrophage phenotype, particularly in humans (24, 28). Therefore, increasing 
knowledge on the monocyte and macrophage biology and signaling hold immense potential 
for enhancing understanding of the etiology of numerous diseases, the dynamics of aging, 
and the impact of lifestyle habits such as diet and physical activity. Unfortunately, technical 
hurdles limit examinations of monocyte and macrophage function in vivo or using primary 
cells (11, 80). Hence, devising a means to reliably measure macrophage function in vitro 
using simulated in vivo conditions may provide valuable insights for later confirmation in 
primary cells. This was the goal of the current project. Upon completion of the 3 project aims 
the following procedure is recommended: 1. THP-1 monocytes cultured to between 800,000-
1,000,000 cells/mL should be differentiated in culture media supplemented with 25 nM PMA 
for 48 hours, followed by 24 hours “rest” without PMA; 2. PMA differentiated THP-1 
MDMs should be incubated in 35% human serum for 3 hours prior to the administration of 
0.5 µg/mL LPS; 3. To measure THP-1 MDM function, following 24 hours LPS incubation 
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culture supernatant should be reserved for analysis of secreted cytokines at a later time, and 
phagocytosis should be assessed immediately. This 3-step procedure provides a novel 
approach to studying macrophage function through the use of human serum incubation to 
simulate in vivo conditions in vitro, providing a means to tackle previously untested research 
questions. With this procedure, future studies will provide new insight on the modulating 
effects of soluble factors in human serum, such as dietary compounds or exercise induced 
changes in hormones, on monocyte-derived macrophage behavior and provide valuable 
information on monocyte and macrophage signaling dynamics in vivo.  
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Figure 1: Diagram of 6x3 plate set-up for PMA optimization experiments. Cells were plated in 
rows A and B. Cells in row A were treated with both PMA and LPS, while cells in row B were 
served as the positive controls and were treated with PMA but no LPS. Columns 1-3 and 4-6 
corresponded to one incubation condition each as detailed below. Only media was added to row C, 
as these wells served as the negative control/background reading. 
Figure 2: Diagram of 6x6 plate set-up for LPS and human serum optimizations. Cells were plated 
to rows A-E. Rows A-D corresponded to one experimental condition each (i.e. 0.1 µg/mL LPS) 
and row E was used as the positive control condition in which cells experienced all treatments 
except for the independent variable (i.e. LPS for LPS optimizations, humans serum for the human 
serum optimizations.) Only media was added to row F, as these wells served as the negative 
control/background reading. 
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Figure 4: Effect of THP-1 monocyte PMA differentiation protocol on the secretion of cytokines 
IL-10, IL-1b, TNF-a, and IL-6 following differentiation and 24 hr incubation with 0.5 µg/mL 
LPS. “LPS” refers to LPS stimulated cells, “+ Control” refers to cells differentiated using the same 
PMA protocol but unstimulated by LPS, and “- Control” refers to background cytokine levels of 
the culture media. Data represent one sample analyzed from each condition. 
Figure 3: Effect of THP-1 monocyte PMA differentiation protocol on phagocytosis following 
differentiation and 24 hr incubation with 0.5 µg/mL LPS. Phagocytosis is expressed as % effect 
relative to cells untreated with LPS but differentiated in the same manner as indicated by the 100% 
dotted line.  “ * ” indicates p<0.01 compared to 96- or 72-hour incubations. Data are presented as 
mean±SD. 
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Figure 5: Effect of LPS concentration on phagocytosis in THP-1 MDMs following 24 hr of LPS 
incubation. Phagocytosis is expressed as % effect relative to cells untreated with LPS as indicated 
by the 100% dotted line. Data are presented as mean±SD 
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Figure 6: Effect of LPS concentration on 
the secretion of cytokines IL-10, IL-1b, 
TNF-a, and IL-6 following a 24 hr 
incubation with THP-1 MDMs. “Pos” 
refers to positive control wells in which 
cells were differentiated using the same 
PMA protocol but unstimulated by LPS, 
and “Neg” refers to negative control 
wells with only THP-1 media (no cells) 
to account for background cytokine 
levels of the culture media. Data 
represent one sample analyzed from each 
condition. 
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Figure 7: Effect of LPS concentration on NucBlue fluorescence in THP-1 monocyte-derived 
macrophages following 24 hr of LPS incubation. NucBlue is expressed in mean fluorescence 
intensity (MFI). “ * ” indicates p<0.05 compared to + Control. Data are presented as mean±SD.  
 
Figure 8: Effect of human serum (HS) concentration in culture media on phagocytosis in THP-1 
MDMs following 0.5 hr HS incubation and 24 hr incubation with 0.5 µg/mL LPS. Phagocytosis is 
expressed as % effect relative to cells incubated for the same time in normal culture media (10% 
FBS) and similarly incubated with LPS, as indicated by the 100% dotted line. Data are presented 
as mean±SD.              
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Figure 9: Effect of human serum (HS) concentration in culture media on phagocytosis following 
1.0 hr HS incubation and 24 hr incubation with 0.5 µg/mL LPS. Phagocytosis is expressed as % 
effect relative to cells incubated for the same time in normal culture media (10% FBS) and 
similarly incubated with LPS, as indicated by the 100% dotted line. “ * ” indicates p<0.01, p<0.05 
between 35% and 10%, 50% conditions respectively. Data are presented as mean±SD.              
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Figure 10: Effect of human serum (HS) concentration in culture media on phagocytosis following 
2.0 hr HS incubation and 24 hr incubation with 0.5 µg/mL LPS. Phagocytosis is expressed as % 
effect relative to cells incubated for the same time in normal culture media (10% FBS) and 
similarly incubated with LPS, as indicated by the 100% dotted line. “ * ” indicates p<0.05 between 
50% and 10% conditions. Data are presented as mean±SD.              
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Figure 11: Effect of human serum (HS) concentration in culture media on phagocytosis following 
3.0 hr HS incubation and 24 hr incubation with 0.5 µg/mL LPS. Phagocytosis is expressed as % 
effect relative to cells incubated for the same time in normal culture media (10% FBS) and 
similarly incubated with LPS, as indicated by the 100% dotted line. “ * ” indicates p<0.001 
between 25%, 35%, 50% and the 10% condition. Data are presented as mean±SD.   
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Figure 12: Effect of human serum (HS) concentration in culture media on phagocytosis following 
4.0 hr HS incubation and 24 hr incubation with 0.5 µg/mL LPS. Phagocytosis is expressed as % 
effect relative to cells incubated for the same time in normal culture media (10% FBS) and 
similarly incubated with LPS, as indicated by the 100% dotted line. “ * ” indicates p<0.05 
between 35% and 10%, 25% conditions. Data are presented as mean±SD 
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Figure 13: Effect of human serum (HS) concentration on phagocytosis in THP-1 MDMs following 
0.5-4.0 hr serum incubation and 24 hr incubation with 0.5 µg/mL LPS. Phagocytosis is expressed 
as % effect relative to cells incubated for the same time in normal culture media (10% FBS) and 
similarly incubated with LPS, as indicated by the 100% dotted line. “ * ” indicates p<0.01 between 
35%, 50% and the 10% HS condition. Data are presented as mean±SD. 
10
% 
HS
25
% 
HS
35
% 
HS
50
% 
HS
0
200
300
400
100
HS Concentration
Ph
ag
oc
yt
os
is
 (%
 E
ffe
ct
)
Mean Phagocytosis by Serum Concentration
* *
Figure 14: Effect of human serum (HS) incubation time prior to 24 hr incubation with 0.5 µg/mL 
LPS on phagocytosis in THP-1 MDMs. Phagocytosis is expressed as % effect relative to cells 
incubated for the same time in normal culture media (10% FBS) and similarly incubated with 
LPS, as indicated by the 100% dotted line. “ * ” indicates p<0.05 between 0.5 hr and  2.0 hr, 3.0 
hr,  4.0 hr conditions. Data are presented as mean±SD. 
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Figure 15: Effect of human serum (HS) concentration and incubation time on the secretion of IL-
10 by THP-1 monocyte-derived macrophages following serum incubation and 24 hr incubation 
with 0.05 µg/mL LPS. “Pos. Control” refers to cells incubated for the same time and manner in 
THP-1 culture media (RPMI-1640 + 10% FBS) rather than HS. “Neg. Control” refers to cytokine 
levels in the THP-1 culture media, no cells.  
Figure 16: Effect of human serum (HS) concentration and incubation time on the secretion of 
TNF-a by THP-1 MDMs following serum incubation and 24 hr incubation with 0.05 µg/mL LPS. 
“Pos. Control” refers to cells incubated for the same time and manner in THP-1 culture media 
(RPMI-1640 + 10% FBS) rather than HS. “Neg. Control” refers to cytokine levels in the THP-1 
culture media and no cells.  
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Figure 17: Effect of human serum (HS) concentration and incubation time on the secretion of IL-
1b by THP-1 MDMs following serum incubation and 24 hr incubation with 0.05 µg/mL LPS. 
“Pos. Control” refers to cells incubated for the same time and manner in THP-1 culture media 
(RPMI-1640 + 10% FBS) rather than HS. “Neg. Control” refers to cytokine levels in the THP-1 
culture media and no cells.  
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Figure 18: Effect of human serum (HS) concentration and incubation time on the secretion of IL-6 
by THP-1 MDMs following serum incubation and 24 hr incubation with 0.05 µg/mL LPS. “Pos. 
Control” refers to cells incubated for the same time and manner in THP-1 culture media (RPMI-
1640 + 10% FBS) rather than HS. “Neg. Control” refers to cytokine levels in the THP-1 culture 
media and no cells.  
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Figure 19: Concentration of cytokines 
IL-10, TNF-a, IL-1b, and IL-6 within 
the media used for human serum (HS) 
incubation experiments. 50% HS media 
was a mixture of RPMI-1640 with 50% 
HS by volume. THP-1 media was mixed 
as detailed in “Methods” and contained 
10% FBS. 
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Figure 20: Effect of HS incubation time on NucBlue fluorescence in THP-1 MDMs following 24 
hr of LPS incubation. NucBlue is expressed in mean fluorescence intensity (MFI). “ * ” indicates 
p<0.001 compared to 0.5, 1.0, 4.0 hr. “­” indicates p<0.001 compared to 0.5 hr. Data are 
presented as mean±SD.  
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